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ABSTRACT 
 
Neuropeptides regulate cell-cell signaling and influence many biological processes in 
vertebrates, including development, growth, and reproduction. The complex processing of 
neuropeptides from prohormone proteins by prohormone convertases, combined with the 
evolutionary distance between the chicken and mammalian species that have experienced 
extensive neuropeptide research, has led to the empirical confirmation of only 18 chicken 
prohormone proteins. To expand our knowledge of the neuropeptide and prohormone convertase 
gene complement, we performed an exhaustive survey of the chicken genomic, EST, and 
proteomic databases using a list of 95 neuropeptide and 7 prohormone convertase genes known 
in other species. Analysis of the EST resources and 22 microarray studies offered a 
comprehensive portrait of gene expression across multiple conditions. Five neuropeptide genes 
(apelin, cocaine- and amphetamine-regulated transcript protein, insulin-like 5, neuropeptide S, 
and neuropeptide B) previously unknown in chicken were identified and 62 genes were 
confirmed. Although most neuropeptide gene families known in the human are present in the 
chicken, several genes are not present in the chicken. Conversely, several chicken neuropeptide 
genes are absent from mammalian species, including C-RF amide, c-type natriuretic peptide 1 
precursor, and renal natriuretic peptide. The prohormone convertases, with one exception, were 
found in the chicken genome. Bioinformatic models used to predict prohormone cleavages 
confirm that the processing of prohormone proteins into neuropeptides is similar between 
species. Neuropeptide genes are most frequently expressed in the brain and head, followed by the 
ovary and small intestine. Microarray analyses revealed that the expression of adrenomedullin, 
chromogranin-A, augurin, neuromedin-U, platelet-derived growth factor A and D, 
proenkephalin, relaxin-3, prepronociceptin, and insulin-like growth factor I was most susceptible 
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(P-value < 0.001) to changes in developmental stage, gender, and genetic line, among other 
conditions studied. Our complete survey and characterization facilitates understanding of 
neuropeptides genes in the chicken, an animal of importance to biomedical and agricultural 
research. 
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CHAPTER 1: INTRODUCTION  
 
Many biological processes of health, well-being, and economic importance, including 
reproduction, development, growth, memory, and behavior are influenced by neuropeptides 
(Fricker, 2005; Hook et al., 2008).  Neuropeptides are intercellular messengers that result from 
the post-translational cleavage and modification of prohormone proteins. Insights into these 
biological processes, molecular-assisted programs to select livestock species, and molecular-
based tools to prevent, diagnose, and treat health disorders can be gained from the identification 
and functional characterization of neuropeptide genes and products. The first complete draft of 
the chicken genome was available in 2004 (International Chicken Genome Sequencing 
Consortium, 2004).  However, few chicken neuropeptides are known, and few studies focus on 
profiling the expression of multiple chicken neuropeptide genes. In addition, no attempt has been 
made to predict chicken prohormone cleavages that could result in bioactive neuropeptides. The 
objective of this thesis research project was to address the previous limitations and conduct a 
genome-wide survey and functional annotation of chicken neuropeptide and associated enzyme 
genes.  The aim of the following literature review is to present an overview of the various 
genome and bioinformatic tools and resources used to accomplish the objective.
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Chicken Genome 
The chicken is the first agricultural animal to have its genome sequenced (International Chicken 
Genome Sequencing Consortium, 2004). The chicken genome is about one third the size of 
mammalian genomes, reflecting a substantial reduction in interspersed repeat content and 
segmental duplications (International Chicken Genome Sequencing Consortium, 2004).  The 
chicken genome has a haploid content of 1.1 x 10
9
 base pairs of DNA and is divided among 39 
chromosomes, including 38 autosomes and one pair of sex chromosomes, with the female as the 
heterogametic sex (ZW female, ZZ male).  Among the 39 chromosomes, 9 pairs of cytologically 
distinct macrochromosomes and 30 microchromosomes are present (Burt, 2007).  
Microchromosomes are a universal characteristic of all avian species. The typical avian 
karyotype contains usually around 30 pairs of small to tiny (between 23 and 7 Mb) 
microchromosomes. Recent work has shown that even though these chromosomes represent only 
25% of the genome, they encode 50% of the genes (Burt, 2002). 
 
In order to minimize heterozygosity and provide sequence for both the Z and W chromosomes, 
DNA of a single female of the inbred line of red jungle fowl (Gallus Gallus) was used by all 
sequencing libraries (International Chicken Genome Sequencing Consortium, 2004).  A critical 
step in completing the sequencing of the chicken genome was high-throughput DNA sequencing 
of expressed sequence tags (EST) from tissue-specific cDNA libraries generated from several 
international projects (Cogburn et al., 2007). The assembly was generated from around 6.6 x 
coverage in whole genome shotgun reads, which is a combination of plasmid, fosmid, and 
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bacterial artificial chromosome (BAC)-end read pairs (International Chicken Genome 
Sequencing Consortium, 2004). In principle, BACs are used like plasmids; BACs are constructed 
from DNA of an organism (such as humans) and are inserted into a host bacterium.  As the 
bacterium grows, BACs are replicated. Huge pieces of DNA can be easily replicated using BACs 
(Cogburn et al., 2007).   
 
Chicken genomics has major applications and benefits in comparative genomics, evolutionary 
biology, development, and disease. The availability of new tools, such as whole genome gene 
expression arrays and single nucleotide polymorphism panels, coupled with the genome 
sequence, will enhance the use of the chicken as a model organism. 
 
2.2 Chicken as a Model Organism 
The chicken is considered to be the premier non-mammalian vertebrate model organism 
(McPherson et al., 2009).  According to a review from Burt (2007), the roots of avian genomics 
go back to the emerging field of genetics over 100 years ago and many familiar terms, such as 
alleles, genetic linkage, and epistasis, were based upon the work with chicken morphological 
traits. Dodgson and Romanov (2004) stated that birds and mammals last had a common ancestor 
about 300 million years ago.  From an evolutionary standpoint, the chicken can provide a 
valuable comparison to mammalian gene structure and function (Dodgson and Romanov, 2004); 
Basically, the assembly of the chicken genome sequence fills a gap in our knowledge in the 
evolution and conservation of vertebrate genomics (Burt, 2006). Extensive conservation of 
synteny between chickens and mammals was revealed through a comprehensive analysis of gene 
mapping data, along with analysis of sequences of vertebrate genomes (Burt, 2007). Chickens 
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have shown to retain an enormous amount of genetic diversity, and a large amount of these 
alleles have relevance to traits of interest in human biology (Dodgson and Romanov, 2004).   
 
The chicken is extremely useful as a model species in the areas of developmental biology, 
virology, oncology, and immunology (Dodgson and Romanov, 2004).  Because embryonic 
development occurs in ovo rather than in utero, one has ready access to the chicken embryo, 
which allows for direct manipulation and biochemical analysis (McPherson et al., 2009). In the 
area of virology, chickens were used as hosts in the discovery of retroviruses. The avian leukosis 
viruses (ALV) continue to be among the most intensely studied retroviral models (McPherson et 
al., 2009). Similarly, the first tumor virus (Rous sarcoma virus) and first oncogene were derived 
from chicken-based research (Dodgson and Romanov, 2004).  Analysis of the chicken immune 
system provided the first indications of the distinctions between T and B cells; the B cell 
nomenclature derives from their origin in the chicken bursa of Fabricius (McPherson et al., 
2009).  Humans and chickens are infected by many common or related pathogens and have 
multiple similar resistance and susceptibly mechanisms (Dodgson and Romanov, 2004). The 
chicken is also an ideal model for genetic mapping and quantitative trait loci (QTL) analysis. The 
chicken reproduces rapidly, allowing several generations to be generated quickly, and has a large 
number of highly inbred lines available (McPherson et al., 2009).  Overall, the chicken is an 
ideal model organism with which to compare mammalian genome structure and evolution. 
 
The availability of the chicken genome and annotated set of genes provides new opportunities for 
whole genome based gene association and gene expression-based investigations.  The chicken 
genome resource enabled two main research paths that were explored in this thesis project: the 
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identification of all the neuropeptide genes (and associated enzymes) in the chicken genome and 
the use of microarray gene expression experiments to profile the expression of thousands of 
neuropeptide genes (and enzymes) simultaneously. A literature review that provides background 
information on both paths is hereby presented. 
 
2.3 Neuropeptides 
Neuropeptides are biologically active peptides typically 3-40 amino acids in length.  
Neuropeptides act as peptide neurotransmitters and peptide hormones.  More than 100 
neuropeptide genes have been reported across species and taxa (Southey et al., 2006a; Tegge et 
al., 2008). Peptide neurotransmitters mediate neurotransmission, while peptide hormones 
mediate cell-cell communication. The same neuropeptide often serves important roles both as a 
neurotransmitter in the nervous system and as a peptide hormone in the peripheral endocrine 
system (Hook et al., 2008). Neuropeptides have many diverse biological functions that affect 
almost every brain system and neuronal network, as well as influence development and behavior.  
Some functions include regulation of reproduction; growth; water and salt metabolism; 
temperature control; food and water intake;  and cardiovascular, gastrointestinal, and respiratory 
control (Strand, 1999). For example, recent studies observed with mice suggest that 
adrenomedullin (ADML) has a neuroprotective function.  Possibly, it plays a role in maintaining 
homeostasis under normal and stress conditions. (Fernández et al., 2008). Studies with mice and 
humans have shown that pro-melanin-concentrating hormone (MCH) is associated with food 
intake, and possibly obesity (Hervieu, 2003). Prepronociceptin (PNOC) is widely distributed in 
the central nervous system, and studies with humans have shown that it plays a role in memory 
process (NCBI, 2009).  Neurotensin (NEUT) has shown to involved in the maintenance of gut 
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structure and function and in the regulation of fat metabolism in the chicken (Esposito et al., 
1997). 
 
Neuropeptides are formed from large protein precursors, prohormones, which are progressively 
split by specific proteolytic enzymes (Hook et al., 2008; Strand, 1999). Prohormone precursors 
require proteolytic processing to liberate the active neuropeptide.  Proteolytic processing occurs 
at dibasic and monobasic sites (arginine or lysine), as well as multibasic sites (Duckert  et al., 
2004; Hummon et al., 2006; Southey et al., 2006b; 2008ab; 2009). The precursor proteins may 
contain one or multiple copies of the active neuropeptide (Hummon et al., 2006; Strand, 1999). 
 
Proteolytic processing is a key process required for the biosynthesis of numerous active 
neuropeptides from their inactive precursors. Biosynthesis begins with the translation of the 
respective mRNAs to generate the preprohormone precursors.  Proteolytic processing occurs 
cotranslationally at the rough endoplasmic reticulum where the NH2-terminal signal peptide of 
the preprohormone is cleaved by a signal peptidase. The resulting prohormone is routed through 
the Golgi apparatus.  There, it is packaged into newly formed secretory vesicles together with 
processing proteases. Proteolytic processing occurs as the secretory vesicle matures so that the 
mature secretory vesicle contains a processed, biologically active neuropeptide that awaits 
cellular stimuli for regulated secretion (Hummon et al., 2006; Hook et al., 2008).  Some 
neuropeptides undergo posttranslational modifications that may change the biological activities 
of the peptides. Posttranslational modifications that may alter the activities of neuropeptides 
include disulfide bond formation, glycosylation, COOH-terminal α-amidation, phosphorylaton, 
sulfation, and acetylation (Hook et al., 2008).  
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2.4 Prohormone Convertases 
Prohormone convertases (PCs) are a  family of evolutionary conserved dibasic and monobasic 
specific Ca
2+
 -dependent serine proteases of enzymes that clip off the active segments from a 
peptide at single, specific basic residues or pairs of basic residues (Strand, 1999). All 
prohormone convertases consist of a single peptide, a propeptide at the N-terminal end, a highly 
conserved catalytic segment, and a well conserved 150 amino acid downstream region known as 
a homo P-doman  (Strand, 1999). The catalytic domain is the site where cleavage occurs, and 
this site has specificity for prohormones with multi-basic amino acid characteristics.  This family 
of enzymes resemble a bacterial protease called subtilisin, with extensive homologies in their N-
terminal portions (Strand, 1999). The seven known PC family members are: PC1, PC2, PC3 (or 
furin), PC4, PC5, PC6, and PC7 (Baea et al., 2008). The N-terminal pre-regions are signal 
peptides that direct the precursors which are post translationally modified to generate the mature 
molecule (Duckert et al., 2004). Prohormone convertases have been reported in several 
invertebrates, and have been demonstrated to possess highly conserved features across much of 
the animal kingdom, suggesting a similar mechanism across species for cleaving prohormones 
(Morash et al., 2009).  
 
Most research on neuropeptides has been conducted on the human, the rat, and the mouse. A 
simple search in the scientific literature database PubMed 
(http://www.ncbi.nlm.nih.gov/pubmed) for neuropeptide and human, rat, mouse, or chicken 
resulted in 18,553, 16,312, 6,819, and 2,530 hits respectively. Although the number of 
neuropeptide literature references in chicken was high, only 17 chicken neuropeptides had been 
experimentally confirmed as of September 2009.  Information on a large number prohormone 
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and PC sequences, including nucleotide and amino acid sequences, corresponding neuropeptides, 
and references across multiple species, is available in numerous public databases. This 
information was used to construct a master list of neuropeptide and PC genes that was in turn 
used to search for homologues genes in the chicken genome. The next sections summarize the 
bioinformatics resources and tools used in this thesis research project to detect all chicken 
neuropeptide and PC genes.  Bioinformatics uses  "informatics" techniques such as databases, 
algorithms, computer science, and statistics in order to understand and solve problems arising 
from biological data. 
 
2.5 Bioinformatic Resources 
 
UniProt. The UniProt (Universal Protein Resources, http://www.uniprot.org/) database is a 
comprehensive catalog of protein sequences and functional annotations and is a central resource 
for storing and interconnecting information from large and disparate sources (The UniProt 
Consortium, 2006).  UniProt encompasses the UniProt Knowledgebase (UniProtKB) that was 
used in this study. 
 
UniProtKB. The UniProtKB (http://www.uniprot.org/) database is the central foundation for the 
collection of functional information on proteins with accurate, consistent, and rich annotation.  
Core data mandatory for each UniProtKB entry includes amino acid sequence, protein name or 
description, taxonomic data, and citation information (NCBI, 2009). Other annotation 
information, such as widely accepted biological ontologies, classifications, and cross-references, 
are also often added. UniProtKB consists of two sections, UniProtKB/Swiss-Prot, which contains 
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manually reviewed annotated entries, and UniProtKB/TrEMBL, which contains computer-
annotated entries that are awaiting full manual annotation  and review  (NCBI, 2009).  
UniProtKB/Swiss-Prot contains annotated information on protein or peptide function, catalytic 
activity, subcellular location, disease, structure, and post translational modifications. During the 
annotation process, different reports for a single protein are merged in order to have minimal 
redundancy and to improve sequence reliability. Cross-references are provided to various 
underlying nucleotide sequence sources and other useful databases, such as organism-specific, 
domain, family, and disease databases (The UniProt Consortium, 2006).  UniProtKB/TrEMBL 
contains high quality computationally analyzed records that are enhanced  by automatic 
annotation and classification. This database contains the translations of all coding sequences 
present in European Molecular Biology Laboratory (EMBL), GenBank of NCBI, and DNA Data 
Bank of Japan (DDBJ) Nucleotide Sequence Databases.  According to defined annotation 
priorities, records are selected for full manual annotation and integration into UniProtKB/Swiss-
Prot.  Once in UniProtKB/Swiss-Prot, a protein entry is removed from UniProtKB/TrEMBL 
(The UniProt Consortium, 2006).  Information from both Swiss-Prot and TrEMBL databases in 
UniProt (release 15.8, September 22, 2009) was considered in this study. 
 
GenBank. GenBank (http://www.ncbi.nlm.nih.gov/Genbank/ ; release 173.0, August 15, 2009) 
is an annotated sequence database collection produced at the National Center for Biotechnology 
Information, or NCBI.  GenBank consists of all publically available nucleotide sequences and 
their protein translations and is built by direct submissions from individual laboratories, as well 
as from bulk submissions from large-scale sequencing centers (NCBI, 2009). Bulk submissions 
include expressed sequence tags (ESTs), genome survey sequence (GSS), and other high-
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throughput data (Benson et al., 2009).  As of early 2009, GenBank includes over 95 billion 
nucleotide bases from more than 92 million individual sequences, with 16 million new sequences 
added in the past year. The contributions of the Whole Genome Shotgun (WGS) projects have 
supplemented this data to bring the total to 213 billion bases (Benson et al., 2009).  
 
Sequences are classified using a comprehensive sequence-based taxonomy developed by NCBI 
and collaborators.  Each GenBank entry consists of a description of the sequence, the scientific 
name and taxonomy of the source organism, bibliographic references, and a table of features 
listing areas of biological significance, such as coding regions and their protein translations, 
transcription units, repeat regions, and sits of mutations or modifications. To support specific 
sequencing strategies, files in GenBank are partitioned into 20 divisions, including high-
throughput genomic (HTG) and EST (Benson et al., 2009).  
 
High Throughput Genomic. The HTG division consists of transition unfinished large-scale 
genomic records, including sequences which are of draft quality but may contain 5'-UTRs and 3'-
UTRs, partial-coding regions and introns (Benson et al., 2009). Records are characterized 
according to quality of data as Phase 0-3,  with Phase 3 being a finished state. Once finished, 
HTG records are moved into GenBank (Benson et al., 2009). Quality assurance checks of each 
GenBank record include both a sequence and annotations. After quality control, the database 
record is assigned a unique identifier known as an Accession number.  If part of a nucleotide 
sequence encodes a protein, a conceptual translation is annotated.  A protein accession number is 
assigned to the translation product and is linked to a record for the protein sequence in NCBI's 
protein databases (NCBI, 2009). 
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EST. An expressed sequence tag, or EST, is a short sub-sequence of a transcribed cDNA 
sequence (Adams et al., 1991). Expressed sequence tags have been critical in gene discovery and 
sequence determination, as well as in identifying gene transcripts (Adams et al., 1991). This 
influence stems from the fact that ESTs are produced via one-shot sequencing of a cloned 
mRNA.  Basically, several hundred base pairs are sequenced from a cDNA clone taken from a 
cDNA library. Due to the fact these clones consist of DNA complimentary to mRNA, ESTs 
represent portions of expressed genes (Adams et al., 1991).  
 
Expressed sequence tags are a tool in which to refine predicted transcripts for genes, leading to 
prediction of their protein products and eventually of their function. For example, the situation in 
which ESTs are obtained, such as tissue or organ, gives information on the conditions in which 
the corresponding gene is acting.  The design of precise probes for DNA microarray can be 
compiled from EST information that can then be used to determine gene expression (Adams et 
al., 1991). ESTs comprise over 30 billion nucleotide bases in GenBank (Benson et al., 2009). 
Through sequence homology (e.g. BLAST) searches, NCBI identifies all homologies for EST 
sequences and incorporates them into a dbEST database (http://www.ncbi.nlm.nih.gov/dbEST/ ) 
to be further incorporated into the UniGene database (Benson et al., 2009).  
 
Genome. This database represents the current public build of the genome. The sequences in this 
database will have RefSeq accession numbers or type. These represent either contigs (from a 
clone based assembly) or supercontigs (from a whole genome shotgun or composite assembly). 
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The contigs in this database are from only the reference assembly. This database is generated at 
the time of a genome release (NCBI, 2009).  
 
In this study  HTGS, EST, and Genome databases stemmed from the chicken genome build 2.1. 
 
Entrez Gene. This resource, also known as Gene, is NCBI's searchable gene-specific database 
comprised from RefSeq genomes. RefSeq is NCBI's reference sequence project aimed at 
collecting high quality, well annotated sequences of many types, including complete genomes, 
complete chromosomes, genomic regions, mRNAs, genome contigs, and proteins (Strand, 1999). 
The entries in this database result  from a combination of both manual curation and automated 
analyses (Maglott et al., 2005). Each integer that is species specific is given a GeneID identifier 
(Maglott et al., 2005). Entrez Gene contains data for more than 3.2 million genes from over 
4,500 organisms (Sayers et al., 2009). Focus is put on genomes that have been completely 
sequenced, have an active community to contribute gene specific information, or that are 
scheduled for intense sequence analysis (NCBI, 2009). Unique integer identifiers for genes and 
other loci for a subset of model organisms are provided in the database, as well as all information 
associated with those identifiers, thus, establishing a gene-to-sequence relationship. Maintained 
information includes nomenclature, chromosomal localization, gene products and their attributes, 
associated markers, phenotypes, and interactions. If available, results of the analyses that have 
been done on the sequence are provided.  These results can include graphic summary of the 
genomic context; intro/exon structure and flanking genes; a link to a graphic view of the mRNA 
sequence; links to gene ontology and phenotypic information; links to corresponding protein 
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sequence data and conserved domains; and links to related resources (NCBI, 2009). The Gene 
repository also has links to the UniGene database. 
 
UniGene. The UniGene (http://www.ncbi.nlm.nih.gov/unigene; build #41) database 
encompasses transcript sequences that appear (based on sequence similarity) to belong to the 
same transcription locus in the genome together with information on protein similarities, gene 
expression, cDNA clone reagents, and genomic location (NCBI, 2009). GenBank sequences are 
partitioned into clusters, each of which represents a unique gene. These clusters contain both 
mRNA sequences and ESTs, allowing representation of both known genes and putative genes 
based on expressed material that has been sequenced. To build clusters, all mRNA and EST 
sequences are compared, and overlapping sequences are assigned to the same cluster.  Clusters 
containing full-length mRNA should have all ESTs deriving from the gene align with the 
mRNAs. In the case of clusters containing only ESTs, algorithms by which UniGene is built 
assemble the clusters out of overlapping ESTs in order to produce a picture of the gene from 
which it was putatively derived (Strand, 1999). Each successful cluster results in a UniGene 
entry containing information about the cluster including species, gene name, chromosome 
location, tissue distribution, and sequence information (NCBI, 2009). The information about the 
distribution of mRNA and ESTs expression available in the UniGene database allows to 
characterize the expression of genes across tissues, body parts, and developmental stages. Thus, 
UniGene is an excellent resource for designing tissue-specific microarrays for focused research 
projects. In our research, UniGene was used to profile the expression of chicken neuropeptide 
ESTs across tissues and stages. However, the gene expression profiles in UniGene are limited to 
variation across tissues and developmental stages. One of the objectives of the present study was 
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to compile a comprehensive annotation of the neuropeptide and PC gene expression. This 
annotation would span tissues and stages and also encompass other factors that can affect gene 
expression such as gender, genetic line, and various treatments. To accomplish this, a total of 22 
chicken microarray experiments available in the Gene Expression Omnibus database (GEO) 
were analyzed and summarized. 
 
Gene Expression Omnibus. The GEO database is a data repository and retrieval system for 
microarray and other forms of high-throughput molecular abundance data generated by the 
scientific community (Sayers et al., 2009; NCBI, 2009).  A survey of the chicken microarray 
experiments available in GEO indicated that the Affymetrix in-situ synthesized oligonucleotide 
(GEO GPL3213) was the most commonly used chicken microarray platform. Furthermore, this 
platform had the highest representation of neuropeptide and PC genes including 53 neuropeptide 
and 5 PC genes transcripts. Therefore, all the chicken microarray experiments that used this 
platform available in GEO as of September 2009 were used in this study. The gene probes in the 
Affymetrix microarray platform are identified in the GEO database using the UniGene 
identifiers. The identification is based on the homology or similarity of the probe sequence to the 
gene sequence. The most commonly used program to align individual sequences (e.g. a 
microarray probe sequence) to a database of sequences (e.g. Gene or UniGene gene sequences) 
and identify homologues is BLAST.  
 
 
2.6 Basic Local Alignment Tool 
Basic Local Alignment Tool, or BLAST, is a set of similarity search programs designed to 
explore all of the available sequence databases.  The program finds regions of similarity between 
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sequences and calculates a statistical significance score (NCBI, 2009).  This score has a well-
defined statistical interpretation, making real matches easier to distinguish from random 
background hits (Altschul et al., 1990). Nucleotide or protein sequences are compared to various 
sequence databases in order to understand functional and evolutionary relationships between 
sequences, as well as identify members of gene families (NCBI, 2009). The BLAST program 
uses a heuristic algorithm that seeks local alignment, rather than global alignment, allowing it to 
detect relationships among sequences that share only isolated regions of similarity (Altschul et 
al., 1990). 
 
Determining common evolutionary ancestry, or finding homology between sequences, is 
fundamental to understanding the function of genomic sequences.  Comparing two sequences for 
homology, one of which has known function, structure, or origin, allows inferences about the 
second unknown sequence to be made. Usually, homologous sequences share common elements 
of three-dimensional folding and secondary structure, although this is not always the case.  When 
the statistical similarity between two sequences exceeds a threshold, homology is inferred. 
Similarity is measured through computing a local alignment, typically using a variant of the 
Smith-Waterman algorithm (a dynamic programming algorithm that evaluates all possible 
alignments between sequences to identify the best local alignment between two sequences) to 
find similar regions between two sequences. Point mutations or elementary changes that 
transform a sequence region in one sequence into a region in another are measured and then 
expressed as a probability that the score has arisen by chance. All possible alignments between 
two sequences are computed with a scoring scheme to compute an optimal local alignment.  
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Scoring of local alignment typically relies on a mutation data matrix and experimentally derived 
penalties for gaps (Cameron et al., 2004). 
 
2.7 The Sequence Alignment E-Value 
Statistical significance of each gapped alignment is expressed as an E-value. Three stages 
determine this value, an indicator of the degree of similarity between two aligned sequences. 
1) A nominal score S is determined for each alignment using a mutation data scoring matrix and 
a function for penalizing gaps. The mutation scoring matrix is a matrix that places values to the 
alignment of identical (matches) and dissimilar (mismatches) nucleotides or amino acids. For 
example, amino acids that have different physical and chemical properties have negative or 
lower positive scores, meanwhile the alignment of identical amino acids have the highest scores. 
Also, matches between common amino acids have lower positive scores than matches of 
infrequent amino acids. Different mutation matrices have been created to address different 
evolutionary distances between sequences. For example, a mutation scoring matrix suitable for 
aligning evolutionary proximal sequences places more extreme positive and negative scores for 
the matches and mismatches, respectively; meanwhile a matrix suitable for distant sequences 
places less extreme scores for matches and mismatches because more changes (mutations) 
between the sequences are expected. Users can select from a range of mutation score matrices 
depending on the anticipated or desired distance between the query sequence (e.g. mouse 
neuropeptide Y gene sequence) and the sequences on the database (e.g. all the chicken sequences 
in the Genome database). 
2) The nominal score is converted to a normalized S' score: 
   S' = (λS- ln K) ÷ ln 2     [1] 
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where the values of λ and K are precomputed by random simulation for each scoring matrix and 
gap penalty combination. The purpose of the normalization is to adjust the nominal score by the 
scoring matrix used.  
3) The normalized score in converted into an E-value: 
   E = Q ÷ 2
S'
       [2] 
where Q is the search base size; Q is approximately equal to m×n, where m and n are the total 
number of residues in the query and the collection sequences, respectively (Cameron et al., 
2004). The appeal of the E-value is that it is more comparable to a P-value than the normalized 
score. E-values are positive with low values (e.g. E-value < 1×10
-5
) indicating strong evidence of 
sequence similarity. Furthermore, the E-value adjusts for the size of the database and query 
sequences, as longer sequences are expected to have higher scores and lower E-values by chance 
alone.  
 
2.8 Gene Expression Microarray Technology 
A DNA microarray is used to detect the presence and abundance of labeled nucleic acids in 
samples. Microarrays allow the simultaneous measurement of the expression of thousands of 
genes across treatments, developmental stages, or other conditions. The probes in the microarray 
can be oligonucleotides (or cDNAs) that are a perfect complementary match to a segment of the 
gene of interest. Gene expression describes the transcription of information contained within 
DNA into messenger RNA (mRNA) that is then translated into the proteins critical for the 
functions of cells (NCBI, 2009). By examining the amounts of mRNA that are produced by a 
cell, scientists are able to identify which genes are expressed, which in turn reveals how cells 
adapt to changes within and outside of the organism due to treatments or other conditions.  
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Changes in gene expression levels can be a suitable indicator of the changes in the abundance of 
protein (Stekel, 2003). Data from multiple microarray experiments are available in public 
databases like the Gene Expression Omnibus (GEO; http:// www.ncbi.nlm.nih.gov/geo ), and the 
most commonly used chicken microarray platform is the Affymetrix in-situ synthesized 
oligonucleotide array. 
 
Affymetrix In-Situ Synthesized Oligonucleotide Array Technology 
Oligonucleotides are short (i.e. 20 to 80 nucleotides long) segments of RNA or DNA synthesized 
by cleaving longer segments, or by polymerizing individual nucleotide precursors.  During in-
situ synthesis, oligos are built up base-by-base on the surface of the array (Stekel, 2003).  This 
occurs by a covalent reaction between the 5’ hydroxyl group of the sugar of the last nucleotide to 
be attached and the phosphate group of the next nucleotide.  A protective group on the 5’ 
position of each added nucleotide prevents the addition of more than one base during each round 
of synthesis.  Before moving on to the next round of synthesis, the protective group is converted 
to a hydroxyl group. Different methods can be used for this deprotection, with our interest 
focused on the Affymetrix technology.    
 
Affymetrix GeneChip microarrays are high density oligonucleotide gene expression arrays 
widely used in genomics studies (Jiang et al., 2008).  For deprotection, a photodeprotection 
method using masks is employed.  Basically, masks allow light to pass to appropriate features, 
while keeping it from other features, in order to convert the protective group on the terminal 
nucleotide into a hydroxyl group where bases can then be added.  Each step of synthesis requires 
a different mask.  Photodeprotection has a coupling efficiency of about 95%, meaning about 95% 
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of nucleotides are successfully added at each step of synthesis.  The longer the oligonucleotide 
being synthesized, the worse the yield of full length oligos.  The composition of the final 
population of oligonucleotides is influenced by capping, which prevents further synthesis on a 
failed oligonucleotide resulting in all oligonucleotides on a feature to have the same start, but be 
of different lengths. On an Affymetrix microarray, each gene is represented by a probe set 
consisting of 11 different pairs of 25 base pair oligos covering features of the transcribed gene.  
A probe set consists of a series of probe pairs and represents an expressed transcript.  Each pair  
consists of a perfect match (PM) and a mismatch (MM) oligonucleotide.  The PM probe exactly 
matches the sequence of a particular standard genotype, while the MM differs in a single 
substitution in the central, 13th base and is designed to distinguish noise caused by non-specific 
hybridization from the specific hybridization signal.  A single sample that has been previously 
labeled with a fluorescent dye (biotin) is hybridized to the microarray probes, the microarray is 
scanned, and an image of fluorescence intensities is obtained. Gene expression is determined by 
comparing the signal intensity from hybridization to probes complementary to the gene being 
measured with the signal intensity from hybridization to probes that contain mismatches; the 
signal from the mismatch probes are thought to represent cross-hybridization.    
 
Affymetrix Microarray Experiment Protocol. There are four basic steps in using a microarray 
to measure gene expression in a sample: sample preparation and labeling; hybridization; 
washing; and image acquisition.   The Affymetrix platform follows a specific protocol, which 
allows for easier comparison of results between laboratories than other platforms.  First, RNA 
must be extracted from the tissue of interest.  For labeling, one must construct a biotin-labeled 
complementary RNA for hybridizing to the GeneChip.  The GeneChip anchors tens of thousands 
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of closely arrayed oligonucleotide probes on to the surface of solid substrates, where the process 
of recognition can be highly parallel (Xiao et al., 2005).  In hybridization, DNA probes form 
heteroduplexes with labeled DNA (or RNA) via Watson-Crick base pairing.  Slides are washed 
after hybridization to ensure only the target specifically bound to features on the array 
(DNA/RNA we are trying to measure) are left and to reduce cross-hybridization.  Affymetrix has 
integrated its image-processing algorithms into the GeneChip experimental process. Overall, 
oligonucleotide arrays are powerful tools for monitoring gene expression and for resequencing 
genes. 
 
Normalization. Microarray technology is susceptible to technical error even after following the 
recommended experimental protocols. Some of the systematic sources of variation can be 
removed through the process of normalization or preprocessing of the microarray gene 
expression intensities before analysis. Examples of these sources of technical error include arrays 
with higher overall expression levels than others with comparable samples due to scanning or 
labeling, and probes appearing more fluorescent than others due to the nucleotide composition. 
The most common normalization techniques applied to Affymetrix microarray experiments is the 
quantile normalization followed by the GC-Robust Multichip Average or GC-RMA  (Cope et al., 
2004; Speed et al., 1992). The quantile normalization results in all the arrays in an experiment  
having the same distribution, thus the same mean, variance, quantiles, and percentiles. This 
normalization does not remove the within gene changes in expression across treatments or 
samples but removes all systematic differences between arrays across genes. The RMA 
normalization provides a single gene expression value per gene and microarray by combining all 
the probe values within a gene. The CG-RMA adjusts the expression intensity by the 
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composition of bases and location of the bases on the probe. The rationale for this adjustment is 
that the hybridization bond between the complementary probe and sample bases depends on the 
labeling and base. The label typically binds to Cytosine C base, and this can interfere with the 
Cytosine-Guanine bond. However, the C- G bond is stronger than the Adenine-Thymine bond. 
An adjustment formula was developed to account for these factors in the normalization of the 
gene expression measurements. The normalizations of  the microarray experiments in this study 
were implemented in Beehive (http://stagbeetle.animal.uiuc.edu/Beehive). Beehive is a public 
integrated suite of web-based tools to study gene expression data from microarray experiments 
(Smith et al., 2007).  
 
2.9 Prediction of Prohormone Cleavage 
 
Neuropeptides result from multiple cleavages of larger precursor proteins (Southey et al., 
2006b).  The complex and variable posttranslational processing of these precursor proteins 
makes identification of neuropeptides difficult. Cleavage precursors also tend to fluctuate across 
species, tissues, and developmental stages, as well as depend upon structural properties and the 
environment during peptide processing (Fricker, 2005; Tegge et al., 2008). Bioinformatics 
prediction of precursor cleavage sites can support effective biochemical characterization of 
neuropeptides (Tegge et al., 2008).  
 
Comparative genomics and sequence homology are two common approaches for identifying 
precursor proteins (Southey et al., 2006a).  Comparing sequences between well and poorly 
studied species can result in ample identification of precursor sequences, however, it may also 
result in inaccurate predictions of bioactive neuropeptides (Southey et al., 2006a). Sequence 
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homology may also result in inaccurate predictions because any one precursor processing step 
may depend on the presence of specific amino acids or combination of amino acids (or 
physiochemical properties) at specific sequence locations (Tegge et al., 2008).  By considering 
multiple sequence locations, the identification of sequence motifs associated with cleavage can 
overcome some of the prior listed limitations (Southey et al., 2006b).   
 
To gain a conclusive understanding of neuropeptide processing,  there must be simultaneous 
consideration of multiple precursor families, species, and predictive approaches.  Limited 
overlap between approaches and precursor data sets used to train and test cleavage prediction has 
hampered the characterization of precursor cleavages (Tegge et al., 2008). Currently, no phyla-
specific models exist to predict cleavage of neuropeptides in the avian species.  
 
The Logistic Regression model and Known Motif model are two suggested approaches to predict 
neuropeptide cleavage (Southey et al., 2008b).  Analysis of these models results in predictions 
that are categorized into correct cleavage (true positive),  incorrect cleavage (false positive), 
correct noncleavage (true negative), and incorrect noncleavage (false negative). The correct 
classification rate is the number of correctly predicted sites divided by the total number of sites. 
Sensitivity (the percentage of all cleaved sites that were correctly predicted) is the number of true 
positives divided by the total number of sites cleaved, and specificity (the percentage of all non-
cleaved sites that were correctly predicted) is the number of true negatives divided by the total 
number of sites not cleaved  (Tegge et al., 2008). 
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Logistic Regression model.  The Logistic Regression model provides a probability of cleavage 
resulting from a linear combination of amino acids at different positions, relative to the cleavage 
site, weighted by their association with the cleavage (Southey et al., 2006b). This probability of 
cleavage, пi, corresponding to the i
th
 window is described as 
𝑙𝑜𝑔 𝜋𝑖   1− 𝜋𝑖)  ] =  𝛽𝑗
𝑝
𝑗=1
𝑥𝑖𝑗  
where βj is the regression coefficient associated with the j
th
 model term and xij denotes presence 
or absense of the j
th
 model term (j= 1 to p, amino acid or amino acid property at pericleavage 
locations) in the i
th
 window  (Tegge et al., 2008).  In this study, the human logistic regression 
model was used due to the human having a long-standing sequenced genome and extensive 
empirical validation of neuropeptide and precursor cleavage information on neuropeptides 
(Tegge et al., 2008).  By using models trained on experimentally confirmed data in predicting 
precursor cleavages, some limitations of sequence homology and motif finding are overcome 
(Tegge et al., 2008). 
 
Known Motif model. The Known Motif proposed by Southey et al., 2006b is comprised of 
several prevalent motifs associated with neuropeptide precursor cleavage, Xxx-Xxx-Lys-Lys↓, 
Xxx-Xxx-Lys-Arg ↓, Xxx-Xxx-Arg-Arg↓, Arg-Xxx-Xxx-Lys↓, and Arg-Xxx-Xxx-Arg↓, where 
↓denotes cleavage and Xxx denotes any amino acid. Prohormone cleavages were predicted in 
this study using Neuropred. 
 
Neuropred. Neuropred (http://neuroproteomics.scs.uiuc.edu/neuropred.html) is a web 
application used to predict the cleavage sites of neuropeptide precursors using logistic 
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regression models trained on experimentally verified cleavage information.  Neuropred can 
also be used to calculate model accuracy indicators and neuropeptide masses from predicted 
cleavage cites (Southey et al., 2006a).  
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CHAPTER 3: GENOME-WIDE CENSUS EXPRESSION PROFILING OF CHICKEN 
NEUROPEPTIDE AND PROHORMONE CONVERTASE GENES
1 
 
3.1 INTRODUCTION 
Neuropeptides encompass a wide range of small signalling peptides, such as neurotransmitters 
and peptide hormones, that regulate many biological processes, including reproduction, 
development, growth, memory, feeding, and behavior (Hook et al., 2008). These important 
intercellular messengers derive from larger prohormone proteins via a complex series of post-
translational cleavages, spearheaded by prohormone convertases (PCs) and other post-
translational modifications, which challenge their detection solely based on sequence homology 
to other more extensively studied species (Fricker, 2005; Hook et al., 2008).  The chicken was 
the first avian genome sequenced (International Chicken Genome Consortium, 2004) and thus 
lacks closely related species with neuropeptide sequence information, although the song bird is 
currently being sequenced and annotated.  The availability of the genome sequence allows one to 
uncover genes with limited or no empirical confirmation using bioinformatics tools, and the 
growing number of gene expression microarray experiments supports the functional annotation 
of these genes (Cogburn et al., 2003).   
 
Although approximately 95 neuropeptide genes that code for prohormones have been identified 
in human, only 65 of these genes have been reported or predicted from the chicken genome and, 
in addition, prohormone peptide YY has only been reported at the protein level.  The incomplete 
status of the chicken neuropeptide and PC gene complement is a notable deficiency considering 
the well-recognized status of the chicken as a model organism in biomedical and agricultural 
1Parts of this chapter have been accepted for publication in Neuropeptides and the manuscript (Delfino, K., Southey, B., Sweedler, J., and Rodriguez-Zas, S. Genome-wide census 
expression profiling of chicken neuropeptide and prohormone convertase genes)  is In Press as of November 20, 2009. The copyright owner, Elsevier, has provided permission to 
reprint. 
26  
 
research (Stern, 2005). The role and expression patterns of a small percentage of these 
neuropeptides have been explored in chicken.  Insulin-like growth factor 1 (IGF1) has a role in 
chicken fetal growth, as well as axonal growth and myelination (Duclos, 2005); Bennett et al. 
(2006) identified polymorphisms in IGF1 and insulin (INS) associated with weight at 5 weeks 
and 55 weeks in a layer-broiler cross in chickens; Zhou et al. (2005) reported significant 
associations between IGF1 and bone size and strength in 8-week old female and male chickens.  
Vasoactive intestinal peptide (VIP) relaxes the smooth muscle of trachea, stomach, and gall 
bladder. Jozsa et al. (2006) demonstrated that the brain levels of VIP and pituitary adenylate 
cyclase-activating polypeptide (PACA) change in chicken and rats after food deprivation and 
concluded that the 2 peptides are differentially involved in feeding.  
 
The public Gene Expression Omnibus (GEO) database contains multiple chicken microarray 
gene expression platforms, including many with more than 10,000 probes (e.g. GPL1731, 
GPL1461, GPL1836, GPL2719, GPL2863, GPL3213, GPL4993, GPL5618, GPL6049).  
Although some of these platforms include neuropeptide and PC gene probes, the incomplete 
knowledge of the chicken neuropeptide and PC gene complement has challenged the profiling of 
these genes.  In addition, the ability of mass spectrometry experiments to detect and characterize 
neuropeptides is aided by the availability of accurate prohormone gene identification and 
annotation (Li and Sweedler, 2008). 
 
The objective of this study was to obtain the first genome-wide census and functional annotation 
of chicken neuropeptide and PC genes.  First, an exhaustive master list of known neuropeptide 
and PC genes in the human and chicken was constructed.  Second, the master list was searched 
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against various complementary chicken genome databases.  Third, neuropeptide and PC gene 
expressions were profiled using a database of approximate expression patterns inferred from EST 
sources and a set of 22 chicken microarray experiments.  Lastly, cleavage sites on the 
prohormone protein sequences were predicted and compared to known neuropeptide sequences 
and associated cleavages.  
 
3.2 METHODS 
Detection of Chicken Neuropeptide and Convertase Genes 
A search for neuropeptide and PC genes across the chicken genome (1.1 Mb, including 30 
microchromosomes and 9 macrochromosomes) was undertaken.  A master list of candidate 
genes was generated based on public databases and a literature review (Amare et al., 2006; 
Southey et al., 2008b; Southey et al., 2009). The candidates were first searched for among the 
sequences already available in the GenBank (release 173.0, August 15, 2009) and UniProt 
databases (release 15.8, September 22, 2009).  To uncover genes not previously reported or with 
different nomenclature from that of the master list, the human prohormone gene sequences were 
aligned against three resources stemming from the chicken genome build 2.1, the genome 
(Genome), the expressed sequence tag (EST), and the high throughput genome sequence 
(HTGS) databases available in NCBI. Sequence searches were implemented using the chicken 
NCBI BLAST website 
(http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=9031) with default 
parameters (BLOSUM62 scoring matrix and maximum E-value of 10) and no filtering of low 
complexity regions.  To augment the likelihood of identifying functionally conserved 
homologues, the protein sequence was used as a query.  The matches were screened based on the 
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alignment E-value and distribution of the alignment identities, close matches, mismatches, and 
gaps along the sequence.  The matches were also screened for alignments to related genes in the 
same neuropeptide family.  
 
Characterization of the Neuropeptide and Convertase Gene Expression Profiles 
The expression patterns of neuropeptide and PC genes were obtained from two resources. One 
resource was the UniGene database (build #41) which includes the expression of chicken 
neuropeptide ESTs across tissues and maturation stages. The other resource was the GEO 
database which encompasses gene expression experiments that used chicken microarray 
platforms and included probes for neuropeptide and PC genes.  Affymetrix Chicken Genome 
Array GPL3213 (http://www.affymetrix.com/support/technical/byproduct.affx?product=chicken) 
was selected among the chicken microarray platforms because it had the highest number of 
relevant probes, including 53 neuropeptide and 5 PC gene transcripts.  In addition, the GPL3213 
platform had the highest number of gene expression experiments (22) of all chicken platforms. 
This unique abundance enabled a comprehensive analysis of all the experiments and the 
identification of neuropeptide and PC gene expression patterns across a wide range of conditions.  
The studies were grouped into 6 classes: retina, heart and breast muscle, brain and head, liver 
and duodenum, oocyte and gonad, and other tissues; the number of studies (and GEO series 
identification) within each class was 4 (GSE6543, GSE7176, GSE11439, and GSE15382), 4 
(GSE6843, GSE8693, GSE9251, and GSE15413), 4 (GSE6844, GSE6868, GSE8693, 
GSE12268), 4 (GSE6856, GSE8483, GSE15413-liver, GSE15413-duodenum), 2 (GSE8693, 
GSE10231), and 5 (GSE8010, GSE8016, GSE8018, GSE8483, GSE9884), respectively.  
Experiments GSE8693 (Ellegren et al., 2007) and GSE15413 included comparisons of 
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conditions across multiple tissues, and the samples corresponding to each tissue were analyzed 
separately to facilitate the interpretation of results. 
 
Pre-processing and normalization of the microarray data was done using the Affy R package 
(Irizarry et al., 2009) and included the log2 transformation of the intensities and GC-robust 
multichip average normalization of expression measurements.  The expression measurements of 
all the probes in the platform were analyzed, and the statistical significance of the differential 
expression was adjusted for multiple testing across all probes using the false discovery rate 
approach (Benjamini and Hochberg, 1995).  The microarray analyses were done using Beehive 
(http://stagbeetle.animal.uiuc.edu/Beehive). 
 
Prediction of Cleavage Sites 
Several models have been proposed to predict the cleavage of prohormone proteins coded by 
neuropeptide genes (Hummon et al., 2003; Southey et al., 2006b; Tegge et al., 2008; Southey et 
al. 2008a; Southey et al. 2009).  However, no cleavage model has been trained on avian species.  
The accuracy to predict avian cleavage sites from the "known motif" model (Southey et al., 
2006b) and the logistic regression model trained on human sequences (Tegge et al., 2008) was 
evaluated using the 24 chicken prohormone sequences that have peptide information (and in 
most cases with signal peptide information) available in UniProt.  Both models are available at 
NeuroPred (http://neuroproteomics.scs.uiuc.edu/neuropred.html; Southey et al., 2006a).   
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3.3 RESULTS AND DISCUSSION 
Chicken Neuropeptide Genes 
A master list of 95 potential chicken neuropeptide genes and 7 PC genes were identified from the 
literature review and the Gene, UniGene, and UniProt databases.  Table 1 summarizes the 
distribution of the genes on the master list across the 3 databases used to compile already known 
chicken genes (Gene, UniProt, UniGene) and the 3 databases used to uncover previously 
unreported chicken genes (Genome, HTGS, and EST databases).  Additional information on the 
genes in the master list is available in supplementary material Table S1. 
 
A total of  62  chicken neuropeptide genes were present in the Gene database and among them, 
49 had the corresponding complete or partial prohormone sequence in UniProt.  This count 
includes augurin or esophageal cancer-related gene 4 protein (ECRG4); although not currently 
present in the Gene database, a region in a genomic contig on chromosome 1 
(ref|NW_001471545.1|Gga1_WGA43_2) had been assigned as being similar to ECRG4. Further, 
this count excludes the peptide YY-like (PYY-like) gene because although this peptide is 
reported in UniProt (P29203), no evidence for the corresponding gene sequence was found in 
any of the NCBI databases.  The inability to confirm the UniProt PYY-like entry in other 
databases prompted us to remove this peptide from known chicken peptides.  The proportion of 
prohormones coded by neuropeptide genes in UniProt that had empirical evidence at the protein 
level was 0.37 (18/49, not including PYY) and the remaining prohormones had evidence at the 
transcript level, or were based on sequence similarity or predictions (Table 1).  Of the 62 
neuropeptide genes in the Gene database, 59 had a corresponding record in UniGene.  The 
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absence of UniGene entries for motilin (MOTI), oxytocin (NEU1), and orexigenic neuropeptide 
QRFP (OX26) reflects the lack of ESTs reported for these neuropeptide genes.  
Of the 62 neuropeptide gene sequences in UniGene, 8 were not located in the chicken Genome, 
HTGS, or EST databases.  Gastrin (GAST) and PACA were not located in Genome, HTGS, and 
EST databases, meanwhile C-type natriuretic peptide (ANFC), chromogranin (CMGA), 
prolactin-releasing peptide (PRRP), parathyroid hormone-related protein (PTHR), neuropeptide 
VF precursor (RFRP), and secretogranin-1 (SCG1) were not located in the HTGS database.  
UniProt does not have records for GAST, CMGA, and SCG1 that would support the 
corresponding UniGene records. A likely explanation for the neuropeptide genes not located in 
either of the three databases is that the Genome assembly and EST libraries may be incomplete at 
the locations of these genes.   
 
Chicken Prohormone Convertase Genes 
Of the 7 PC enzymes in the master list, only PC 4 (PCSK4) was not reported in the Gene 
database, and only 2 PC genes were reported in the UniProt database (Table 1).  The 6 chicken 
PCs in the Gene database were confirmed in the chicken Genome, HTGS, and EST databases.  
Five of the PC genes in the Gene database had a corresponding record in UniGene. In addition to 
the UniGene partial record for PC 1 (PCSK1, Gga.9357), UniGene has a record (Gga.31439) 
predicted from the genome that is annotated to be similar to PC 1, although no corresponding 
Gene record for this UniGene record is available. The alignment between these two sequences 
has an E-value of 9 × 10
-154
 and 94% identity. Our survey complements the currently limited 
work on PC in the chicken. Ling et al. (2004) detected PC1 and PC2 mRNA in multiple chicken 
tissues including heart, lung, gizzard, pancreas, spleen, bursa of Fabricius, kidney, adipose tissue, 
32  
 
skeletal muscle, pituitary gland, cerebrum, mid-brain and cerebullum; and Richards and 
McMurtry (2008) reported that PC2 mRNA was mostly expressed in pancreas and 
proventriculus, whereas PC1 mRNA was more expressed in duodenum and brain of chicken. 
 
No suitable match for PCSK4 in the chicken genome was found suggesting that PCSK4 may 
have evolved after the split between chickens and mammals, because PCSK4 is found in 
multiple mammalian species. The absence of evidence for PCSK4 is noteworthy because this 
convertase plays an essential role in the process of fertilization and is located in testicular germ 
cells in mice (Gyamera-Acheampong et al., 2006).  The differences in the reproductive biology 
of mammals and chicken and the overlap of processing of some convertases (Baea et al., 2008) 
bar the conclusion that the absence of PCSK4 may hinder any particular prohormone cleavage or 
presence of a particular neuropeptide in chicken. 
 
Previously Unreported Genes Detected in Chicken 
The bioinformatics approach uncovered evidence for 5 neuropeptide genes that have not been 
previously reported.  Confirmatory evidence in the Genome, HTGS, and EST databases that was 
further validated using complementary resources supports the discovery of evidence for the 
chicken homologues to the neuropeptide genes apelin (APEL), cocaine- and amphetamine-
regulated transcript protein (CART), insulin-like 5 (INSL5), neuropeptide S (NPS), and 
neuropeptide B (NPB).  The multi-step strategy varied across sequences and depended on the 
strength of the evidence, quality of the genome sequence, and availability of homologue 
sequences to confirm these findings. In the first step, 2 criteria were used to rule the finding of a 
previously unreported gene in the 3 databases: a low E-value of the sequence alignment 
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(encompassing a high percentage of identities and similarities with a minimum percentage of 
mismatches and gaps), and conservation of the region encompassing the gene product known in 
human were required.  The additional confirmatory steps unique to each gene and a brief review 
of the implications of our findings in the understanding of chicken physiology, production, and 
health follows. Supplementary materials Table S2 presents a detailed description of sequence 
alignments for each of the 5 neuropeptide genes from the 3 databases, and underlined is the 
region corresponding to the functional neuropeptide known in humans.  
 
APEL. The region of the chicken genome that matched the human APEL sequence (NP_059109) 
contained many gaps that prevented complete identification of chicken APEL from the genome. 
An EST (BU323997) that has a good match (E-value = 0.034) to the human sequence was 
identified, but the resulting BLAST alignment between the human sequence and BU323997 had 
2 sections indicating a probable frame-shift in the EST sequence. The alignment of BU323997 
against a region of the chicken genome on chromosome 4 indicates that an extra nucleotide 'G' in 
the EST not present in the genome sequence is present (Table S2a). After removing this extra 'G' 
and non-coding sequence from the chicken EST, a chicken APEL sequence was predicted. The 
trace archives (NCBI Trace-Other database) was searched using the putative nucleic APEL 
sequence to overcome limitations of the genome assembly. There are only 2 matches to this 
putative sequence which correspond to 2 exons as expected from the genomic structure of  the 
human APEL gene. The detection of APEL in the chicken is significant because this 
neuropeptide has been implicated in a variety of roles in humans, including
 
cardiac function; 
drinking behavior; regulation of adiposity, lipid and energy metabolism; and
 
gastric cell 
proliferation (Higuchi et al., 2007).   
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CART. No clear and prolonged match to the human CART sequence in the chicken genome was 
found, suggesting that the CART gene region was not fully assembled in the chicken. However, 
following the strategy used for APEL, an EST (BM490862) with a good match (E-value = 7 × 
10
-32
) to the human CART sequence was identified.  Considering that the human sequence 
matched the third reading frame of the EST and that the first 2 nucleotides of the EST were 'TG', 
we hypothesized that the EST sequence could be missing the initial 'A' nucleotide that would 
code for the first methionine amino acid in the CART protein.  The start of the sequence was 
confirmed using the chicken trace archives (Trace-Others), and visualization of the matches 
showed that the middle of CART is missing in the genome sequences.  The chicken EST mapped 
to a genomic contig yet to be located on the chicken genome 
(NW_001476554.1|GgaUn_WGA14361_2). The significance of the discovery of CART in the 
chicken is highlighted by its known role in reward, feeding, changes in body weight and fat 
mass, and stress (Asnicar et al., 2001; Kuhar et al., 2002).   
 
INSL5. The search for human INSL5 in the chicken genome results in a match (E-value = 0.11) 
on chromosome 8 that was not attributable to members of the relaxin or insulin gene families. 
The NCBI annotation to this genomic region is "similar to WD repeat domain 78" (WDR78; 
Gene identifier LOC429114). The Map View feature in NCBI indicated that the chicken 
LOC424701 and TCTEX1D1 Tctex1 domain containing 1 gene are adjacent to this gene which 
is remarkable because human INSL5 is located on the negative strand between these 2 genes. 
Although the human INSL5 match was insufficient to identify a chicken INSL5 gene, a putative 
sequence was obtained using 3 fish sequences in the relaxin gene family; Danio rerio (Zebrafish, 
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B1AAQ6_DANRE), Fugu rubripes (Japanese pufferfish, B1AAR5_FUGRU), and Tetraodon 
nigroviridis (Green puffer, B1AAR6_TETNG). The Danio rerio sequence is shorter than the 
other 2 but the overlap is extensive. The alignment of the longer sequences to the chicken 
genome produced 2 very good alignments (E-values = 5 × 10
-20
 and 2 × 10
-16
, respectively) that 
are 1210 bp apart (start of both chicken genome matches are 17631700 and 17630490, 
respectively). Both matching regions are annotated in the genome region as WDR78, further 
confirming that the inaccurate annotation of the chicken WDR78 gene prevented the annotation 
of the chicken INSL5 gene.  The identification of INSL5 in chicken is notable because it has 
been postulated that INSL5 plays a role in gut contractility, remodeling and repair of the 
gastrointestinal tract, and neuroendocrine signaling (Conklin et al., 1999; Dun et al., 2006; 
Haugaard-Jönsson et al., 2009).   
 
NPS. A match (E-value = 2 × 10
-15
) to human NPS was identified on chicken chromosome 6 
(Table S2b). The chicken genomic region that matched the human NPS sequence (± 5000 bp) 
was extracted, and the Wise2 version 2.1.20 software 
(http://www.ebi.ac.uk/Tools/Wise2/index.html; Birney et al., 2004) was used to predict the 
coded protein on the extracted region. The predicted chicken protein matched the complete 
human NPS sequence present in UniProt (Table S2b).  The uncovering of NPS in the chicken 
genome is noteworthy because of its role in behavior (e.g. anxiolytic action, hyperlocomotion, 
wakefulness, altered sleep behavior, panic disorder), and intake (Castro et al., 2009; Pape et al., 
2009). 
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NPB. The search for human NPB in the chicken genome matched a "hypothetical protein" (Gene 
database identifier 769277 LOC769277) on chromosome 18 ( E-value = 2 × 10
-6
).  The genome 
region corresponding to actual bioactive NPB peptide was conserved in the alignment. 
Furthermore, the UniGene entry associated with this hypothetical protein clusters it with 
"anaphase promoting complex subunit 11" representatives from other species including human, 
mouse, and zebra fish. The parsing of the chicken nucleic genomic region of the human match 
using Wise2 uncovered one gene with 2 exons. Exon 1 includes the neuropeptide and is well 
conserved with the human NPB gene that also has 2 exons. Similar analyses using the known 
NPB sequences of the zebra fish and salmon offered results consistent with those obtained using 
the human sequence. The alignment of the NPB prohormone sequences predicted from the 
chicken Trace-Other archives includes gaps indicating that incomplete genome assembly 
prevented the annotation of the chicken NPB gene.  Our discovery of NPB in chicken is 
significant because the NPB/NPW neuropeptide system regulates energy homeostasis, pain, and 
emotion, and NPB exerts strong synergistic anorectic effects in mice when co-administered with 
CRF (Hondo et al., 2008; Aikawa et al., 2008). 
 
Neuropeptide Genes Not Located In Either Chicken or Mammals 
Evidence was  insufficient to locate 26 neuropeptide genes from the master list in the chicken 
genome: intermedin (ADM2), natriuretic peptide B (ANFB), calcitonin-related polypeptide beta 
(CALCB), cortistatin (CORT), galanin-like peptide (GALP), hepcidin (HEPC), insulin-like 3 
and 6 (INSL3 and INSL6, respectively), metastasis-suppressor KiSS-1 (KISS1), neuromedin S 
(NMS), neuropeptide FF (NPFF), neuropeptide W (NPW), proprotein convertase 
subtilisin/kexin type 1 inhibitor (PCSK1N), proenkephalin B (PDYN), putative peptide YY-2 
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(PYY2), pro-relaxin 1 and 2 (REL1 and REL2, respectively), regulated endocrine-specific 
protein 18 (RES18), spexin (SPXN), tachykinin 4 (TAC4), parathyroid hormone 2 (TIP39), 
tachykinin 3 (TKNK), torsin family 2 member A isoform prosalusin (TOR2X), urocortin 
(UCN1), and urocortin 2 (UCN2). Although Gene and UniGene have an entry for chicken torsin 
family 2 member A (XP_415507, Gga.5228), the chicken sequence corresponds to a human 
torsin alternative splicing isoform (TOR2A) that does not code for the neuropeptide salusin, and 
thus was considered not located in the chicken genome. In contrast, 3 neuropeptide genes in the 
master list (C-RF amide, c-type natriuretic peptide 1 precursor, and renal natriuretic peptide) 
were present in chicken but were not located in mammalian species. 
 
A remarkable finding is that the vast majority of the human genes not located in the chicken 
genome have at least 1 neuropeptide gene in the same family present in the chicken genome 
(Table 1).  For example UCN1 and UCN2 are absent from the chicken genome, while urocortin 3 
(UCN3) is present in the chicken genome.  The exceptions to the presence of at least 1 member 
of the neuropeptide family in the chicken genome are CORT, HEPC, KISS1, NPFF, NPW, 
RES18, and SPXN. Burt (2007) noted the low number of genes identified in the chicken genome 
relative to the human genome and hypothesized that more duplication events occurred in the 
human lineage of some genes and more losses of other genes occurred in the avian lineage.  Our 
results reinforce this hypothesis that some neuropeptide genes have undergone substantially 
lower gene duplication in the chicken compared to human. 
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Neuropeptide Gene Expression Across Tissues and Developmental Stages  
The distribution of the expression of most neuropeptide and PC genes available in UniGene was 
used to gain an initial understanding of the expression profiles across tissues and developmental 
stages.  All PC and neuropeptide genes in UniGene, with the exceptions of c-type natriuretic 
peptide 1 (CNP1), CRF, GAST, progonadoliberin 1 (GON1), pancreatic polypeptide (PAHO), 
parathyroid hormone (PTHY), prothyroliberin (TRH), thyroid stimulating hormone subunit beta 
(TSHB), and urotensin 2 (UTS2), had expression information.  For PCSK1, the corresponding 
UniGene record (Gga.9357) did not have expression information, but another UniGene record 
(Gga.31439), annotated as "similar to PC1", was used as proxy because of the availability of 
expression information and similarity to the PCSK1 sequence. Table 2 provides a summary of 
the expression profile of 51 neuropeptide and 6 PC genes across the 5 tissues and 2 stages with 
most frequent neuropeptide gene expression out of 19 tissues or body parts and 4 development or 
maturation stages.  Supplementary materials Table S3 presents the distribution of expression 
across all 19 tissues and 4 stages.   
 
The tissue or body part with highest number of neuropeptide gene expression reports (expressed 
in absolute number and percentage) was the brain (33, 65%), followed by head (21, 41%), ovary 
(18, 35%), small intestine (16, 31%), and heart (13, 25%).  A similar distribution was observed 
for the PCs, with the brain and small intestine being the body parts with highest frequency of 
gene expression.  These results are consistent with the role of neuropeptides in physiology, 
health, and behavior (Hook et al., 2008).  The developmental-maturation stage with the most 
reports of neuropeptide gene expression was adult (42, 82%), followed by embryo (39, 76%).  
The neuropeptide genes with the highest number of reports of expression across tissues or body 
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parts were platelet-derived growth factor alpha polypeptide (PDGFA, 11, 58%), SCG1 (11, 
58%), and ECRG4 (9, 47%).  These results are consistent with neuropeptide research across 
species.  For example, PDGFA is expressed in the seminiferous epithelium and interstitial 
mesenchymal cells, and studies with mice show it may play a role in cell proliferation, migration 
in osteoblastic cells, and in production of Leydig cells (Yang et al., 2008).  Likewise, the 
tyrosine-sulfated secretory protein SCG1, found in a wide variety of peptidergic endocrine cells 
in mice, may play a role in the early phase of neoplastic progression (Lukinius et al., 2003).  
Also, the expression of ECRG4 in multiple tissues, including the heart, brain, placenta, lung, 
liver, skeletal muscle, kidney, and pancreas, suggests a role in the modulation of salt and energy 
homeostasis, cardiovascular function, and cerebral spinal fluid composition (Mirabeau et al., 
2007; Mori et al., 2007).  
 
Although the distribution of expression reports can be influenced by the imbalanced distribution 
of EST libraries and experimental interest across tissues, developmental stages, and neuropeptide 
genes, all chicken tissues and developmental stages had at least 1 neuropeptide gene with a 
UniGene expression report.  This confirms the importance of neuropeptides on all aspects of 
chicken physiology, growth, reproduction, and health.   
 
Expression Profiling Based On 22 Microarray Experiments 
Although the information in UniGene offers a broad picture of the expression of neuropeptide 
and PC genes across a wide range of tissues and stages, additional conditions can influence the 
expression profile.  To fully investigate the variation in neuropeptide and PC gene expression 
across a wide range of conditions and augment the understanding of the impact of these genes on 
40  
 
reproduction, health, growth, and other traits of importance to biomedical research and 
agricultural production, the information from a large number of microarray gene expression 
experiments investigating numerous conditions was mined.  
 
We present results from the first simultaneous analysis of 22 microarray experiments to 
characterize the expression of neuropeptide genes and PCs across a wide range of conditions.  
The in-situ synthesized microarray platform selected has the highest representation of chicken 
neuropeptide and PC genes available in GEO and is most widely used.  A total of 73 probes 
representing 53 neuropeptide and 5 PC genes was available in the platform. The experiments 
were broadly grouped into retina, heart and breast muscle, brain and hypothalamus, liver and 
duodenum, gonad and oocyte, chicken-quail comparisons, and other conditions. To facilitate the 
interpretation of the results, a summary of the experiments and their features (e.g., tissues, 
treatments, age, gender, genetic line) is presented in Table 3. More detailed descriptions of the 
experiments are available in supplementary material Table S4 and in the GEO database.  Due to 
the multiple probes analyzed, a minimum false discovery rate multiple-test adjusted P-value < 
0.05 threshold (corresponds to an approximate unadjusted P-value < 0.005) and a minimum fold-
change equal to 1.25 was used to identify differentially expressed genes. Table 4 summarizes the 
number of probes with differential expression across experimental group and probes 
corresponding to the same gene.  Supplementary materials Table S5 presents the detailed 
distribution of the differential expression level of each probe and experiment. A summary of the 
main findings by tissue group are described below. 
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Retina. The chicken is a well-established model for the human eye and retinal development and 
degeneration (Burt, 2007).  Two independent microarray experiments GSE6543 (McGlinn et al., 
2007) and GSE11439 (Schippert et al., 2008) investigated the effect of myopia and the lens in 
the retina in chicken, respectively. The neurotensin (NEUT) gene was significantly over-
expressed in the treated samples relative to the control samples in both studies.  In addition,  
glucagon (GLUC) and NEUT were over-expressed in the treated samples relative to the control 
in the GSE11439 experiment, and VIP was under-expressed in the treated samples relative to the 
control in the GSE6543 experiment.  These findings confirm the important role of neuropeptides 
in vision in the chicken (Schwippert et al., 1998; Chapman and Debski, 1995). Likewise, from 
experiment GSE7176 (Rizzolo et al., 2007) that studied the chicken retina across embryo 
developmental stages, we uncovered that the expression of gene adrenomedullin (ADML) was 
significantly lower in embryonic day 7, or E7 (P-value < 1 × 10
-6
 and 0.29 average fold change) 
relative to more advanced ages (E10, E14, and E18 ).  Both the ADML peptide and its mRNA 
have been detected in embryonic mice in the outer neuroblastic layer of the retina (Montuenga et 
al., 1997) and in the human retinal pigment epithelial cells, suggesting an important 
physiological role for ADML in eye development (Udono et al., 2000).  On the other hand, the 
variation in the expression of VEGFC across developmental stages was significant (P-value < 
3.0 × 10
-4
) but higher at E7 relative to E10, E14, and E18 (2.24 average fold change).  
Neuropeptide VEGFC is expressed in the retinal astrocytes and promotes both endothelial cell 
proliferation and migration (Alon et al., 1995; Stone et al., 1995; Pierce et al., 1996; Provis et al., 
1997).  Likewise, the expression had a significant fluctuation across stages (P-value < 1.0 × 10
-
16
) with higher expression at E7 relative to E10, E14, and E18 (3.44 average fold change).  This 
profile is consistent with studies in mice that have shown that the PDGFA receptor, which is 
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activated mainly by PDGFA located in retinal neurons, is expressed at all stages of maturation 
and is important for retinal astrocyte proliferation and migration (Mudhar et al., 1993; Fruttiger 
et al., 1996).  Over-expression of PDGFA in transgenic mice causes a significant increase in 
retinal astrocytes, resulting in proportional overgrowth of the retinal vasculature (Fruttiger et al., 
1996).  
 
Experiment GSE15382 (Kubo and Nakagawa, 2009) aimed to investigate the potential impact of 
c-hairy1, a gene that inhibits neuronal differentiation on gene expression.  Our analysis 
uncovered that samples with this gene exhibited over-expression of neuropeptide Y (NPY) (P-
value < 3.0 × 10
-2
, 11.31 fold change) and to a lesser extent, secretogranin 2 (SCG2, P-value < 
2.0 × 10
-2
, 1.13 fold change) relative to control samples.  In addition, the differential expression 
between c-hairy1 and control was similar to that between c-hairy1 and Delta and Wnt2b, 2 other 
genes expected to also inhibit neuronal differentiation.  Thus, c-hairy1 had a strong association 
with the expression of 2 neuropeptide genes that is not observed with the other 2 potential 
inhibitor genes. These results are consistent with reports that NPY, along with its receptors, are 
present in the retina of both mammalian and non-mammalian species (D'Angelo and Brecha, 
2004) and that this neuropeptide may modulate the development of retinal circuitry in rats 
(Bagnoli et al., 2003).  Recent experiments with rats have shown that NPY produces a 2-fold 
increase in retinal neural cell proliferation and promotes the proliferation of committed neural 
immature cells (Álvaro et al., 2008). 
 
Heart and Breast Muscle. Neuropeptides can contract muscles, and the action of a neuropeptide 
is of significance in the control of antagonistic contractions (Cho et al., 1996).  Experiments 
43  
 
GSE6843 (Itoh et al., 2007) and GSE8693 investigated gene expression in embryonic heart 
tissue, and our analyses did not detect differential expression among the neuropeptide genes 
studied between females and males, suggesting that the role of the neuropeptides may be equally 
important in both genders.  On the other hand, neuropeptide gene expression can exhibit 
significant variation across breast muscle at different development stages.  For example, the 
analysis of experiment GSE15413 uncovered numerous neuropeptide genes that were 
differentially expressed in the breast muscle between 7-d-old and just hatched (0-d-old) 
chickens.  Specifically, prepronociceptin (PNOC, 2 probes), PDGFA, platelet-derived growth 
factor beta polypeptide (PDGFB), platelet derived growth factor D (PDGFD), ADML, and 
ECRG4 were over expressed in 0-d-old relative to 7-d-old chickens. These findings are 
consistent with studies that report platelet-derived growth factors are important in avian 
embryonic development (Van Den Akker et al., 2005). Conversely, proenkephalin (PENK) and 
IGF1 were over-expressed in 7-d-old relative to 0-d-old chickens.  No neuropeptide gene was 
differentially expressed between male and female embryo heart samples at 18-d-old in GSE8693 
or between male and female embryos at late stages of development in GSE6843.   
 
Experiment GSE9251 (Zheng et al., 2009) profiled the expression of genes in the breast muscle 
of broiler and layer genetic lines at different ages. Our analysis found that PNOC appears to have 
a quadratic expression pattern, regardless of genetic line, because it is under-expressed in both 
broiler and layer at young (1-d-old) and old (6-wk-old to 8-wk-old) ages relative to intermediate 
ages (2-wk-old to 4-wk-old).  Both lines had similar levels of fluctuation across ages 
(approximate P-value < 0.0005 and approximate maximum fold change 2.22). This result is 
consistent with the role of nociceptin in stimulating locomotion (Florin et al., 1997). The PNOC 
44  
 
gene is highly conserved within the mouse, rat, and human, and studies have shown that it is 
broadly expressed in the nervous system, primarily in the brain and spinal cord (Mollereau et al., 
1996).  For PRRP, SCG2, ANFC, musclin (OSTN), neuromedin-U (NMU), TSHB, TRH, 
somatostatin (SMS), islet amyloid polypeptide (IAAP), gastric inhibitory polypeptide (GIP), 
and tachykinin, precursor 1 (TKN1), the expression at 1-d-old was lower than at older ages in 
both genetic lines, and the fold change did not differ significantly between lines (maximum P-
value = 8.4 × 10
-3
).  The ECRG4 gene was highly differentially expressed (P-value < 1.0 × 10
-16
) 
and had the highest expression in 1-d-old broiler and layers with both lines showing similar fold 
changes.  Gene ADML exhibited differential expression (P-value < 1.0 × 10
-16
) with the level at 
1-d-old being higher than at older ages in broilers; meanwhile for layers, ADML is under-
expressed in 1-d-old chickens relative to older ages, and the level is significantly different 
between the lines in 1 d-old chickens.  The difference in expression between genetic lines may 
be associated with the angiogenic role of ADML, albeit weaker in chicken than in human and 
mouse (Martínez et al., 2006).  The expression of IGF1 varied significantly across ages and lines 
(P-value < 2.4 × 10
-13
) with 2-wk-old chickens having the highest expression among layers, with 
expression not varying across ages within broilers, and not showing a clear pattern, significant 
trend, or deviation at a particular time point. The maximum difference between lines (2.15 fold 
change over-expression in layers relative to broilers) was observed at 2-wk of age.  For the IGF2 
probe set, the minimum expression for both genetic lines was in 1-d-old chickens (P-value < 3.9 
× 10
-3
) and the lines did not differ in the level of expression at that age.  This result does not 
support the hypothesis postulated by Wang et al. (2005) that IGF2 can be a candidate gene 
influencing growth and carcass traits, although their work only used broilers. The differential 
expression (P-value < 8.4 × 10
-5
) of the vascular endothelial growth factor C (VEGFC) gene 
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exhibited the maximum at 2-wk-old across lines.  The differential expression (P-value < 1.0 × 
10
-16
) of vascular endothelial growth factor D (VEGFD) encompassed the minimum and 
maximum expression in 1-d-old and 2-wk-old broilers, respectively.  The level of expression in 
broilers is significantly lower than layers at 1-d-old (P-value < 1.0 × 10
-16
, 2.05 fold change) but 
similar by 2-wk-old.  This result is consistent with work that demonstrated the presence of 
lymphatic capillaries throughout VEGFC and VEGFD in the muscles of humans and mice 
(Kivelä et al., 2007) and the role of VEGFC lymphatic regeneration in tissue repair of the 
intestinal muscle coat (Shimoda and Kato, 2006). For the PENK gene, a linear trend of 
expression can be identified, with lower ages having significantly higher expression (P-value < 
1.0 × 10
-6
) than advanced ages for the broiler line and at lower significance levels for the layer 
line.  The level of expression in broilers was significantly higher than layers at 1-d-old (P-value 
< 4.0 × 10
-4
, 1.61 fold change) but similar by 2-wk-old.  This result is consistent with reports that 
during development, PENK mRNA is abundant in skeletal muscle, bone, and intestine, and that 
the levels of PENK mRNA tend to decrease as mice mature, with the exception of the brain, gut, 
lungs, and heart (Prasad et al., 2008). 
 
Liver and Duodenum. From the analysis of gene expression profiles from experiment 
GSE15413, which compared the liver of chicken at two ages, only IGF1 was found over-
expressed in 7-d-old relative to 0-d-old chickens (P-value < 2 × 10
-4
, fold change 12.47) 
followed by prokineticin 2 (PROK2), which had the same profile but was only moderately 
differentially expressed. These results are consistent with reports that in avian species, IGF1 
mRNA is found in the liver, muscle, kidney, testes, heart, ovary, brain, and intestine, and that the 
metabolic effects of IGF include increased amino acid and glucose uptake (Amills et al., 2003).  
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Also, Wang et al. (2007) reported that the hepatic expression of IGF1 was altered by 
hypothyroidism in chickens. As with heart and muscle, no neuropeptide gene differential 
expression was observed between the liver of female and male chicken embryos (study 
GSE6856; Itoh et al., 2007).  Analysis of the GSE8016 study (Nakao et al., 2008) of liver from 
chicken and quail samples uncovered that PNOC, ADML, REL3, NMU, NPY, and ECRG4 were 
significantly under-expressed in chicken relative to quail (maximum P-value < 7.3 × 10
-3
).  
From the analysis of experiment GSE15413, multiple neuropeptide genes were differentially 
expressed in the duodenum of newly hatched (0-d-old) relative to 7-d-old broiler chickens. The 
genes PENK and INS were significantly over-expressed in 0-d-old chickens (P-value < 9.0 ×   
10
-4
, 6.23 fold change, and P-value < 3.5 × 10
-3
, 14.72 fold change, respectively), and VEGFD 
was borderline over-expressed in 0-d-old chickens (P-value < 7.8 × 10
-2
). The former finding is 
in agreement with studies showing that PENK mRNA is expressed in the human esophagus, 
gastrointestinal tract, pancreas, and gallbladder (Monstein et al., 2006) and enkephalins, such as 
PENK, have potent effects on gastrointestinal function, such as motility (Edin et al., 1980; Bitar 
and Makhlouf, 1982; Reynolds et al., 1984), intestinal secretion (Dobbins et al., 1980; McKay et 
al., 1981; Powell, 1981), and gastric acid secretion (Konturek et al., 1980; Feldman et al., 1980).   
 
Brain and Hypothalamus. The limited number of neuropeptide genes differentially expressed in 
the brains of chickens under different conditions compared to other tissues and body parts was an 
unexpected finding.  This result may be because the conditions compared within these studies 
did not allow the detection of major and consistent differential expression in the samples 
available.  Experiment GSE12268 compared the brain of male and female embryos (6.5-d of 
incubation), and the present analysis determined that the pro-melanin-concentrating hormone 
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(MCH) gene was over-expressed; meanwhile, ECRG4 and GAST were borderline over-
expressed in males (P-value < 2.5 × 10
-2
, P-value < 9.5 × 10
-2
 and P-value < 9.5 × 10
-2
, 
respectively).  These results support the hypothesis that MCH acts as a neuromodulator involved 
in a wide variety of physiological and behavioral adaptations (arousal) with regard to feeding, 
drinking, and reproduction in birds (Cardot et al., 1999).  
Results from the analysis of the other experiment (GSE6844; Itoh et al., 2007) that evaluated 
embryo female and male brains identified REL3 as being differentially over-expressed in 
females (P-value < 9.7 × 10
-3
); meanwhile SCG1 and VIP were over-expressed in males (P-
value < 3.3 × 10
-2
 and P-value < 2.1 × 10
-2
).  Also, the analysis of experiment GSE8693 
detected REL3 as being over-expressed in the brain of females (P-value < 9.7 × 10
-3
) relative to 
males.  The observed profile of REL3 was expected because the relaxin hormone is renowned for 
its function in pregnancy, parturition, and other aspects of female reproduction (Agoulink, 2007). 
Relaxin-3 is a hypothalamic neuropeptide expressed in the nucleus incertus of the brainstem and 
plays a role in energy homeostasis (Tanaka et al., 2005; McGowan et al., 2009).  Lastly, analysis 
of experiment GSE6868 (Rosenquist et al., 2007) that compared treated (homocysteine 
congenital defect cell culture) versus control neural crest samples did not uncover any 
differentially expressed neuropeptide genes. The lack of differential expression of the ADML 
gene in the brain is consistent with a report that the levels of ADML protein are almost 
undetectable in the chicken brain (Zudaire et al., 2005).  
 
Oocyte and Gonads. The analysis of gene expression in oocytes across and within genetic lines 
from experiment GSE10231 uncovered that UTS2 was over-expressed in the genetic line with 
the long fertile period (DPF+) compared to the short fertile period (DPF-), high-growth (HG+), 
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and non-high-growth (HG-) genetic lines. This outcome is consistent with the role of UTS2 in 
reproduction that is associated with its spasmogenic activity and in humans, UTS2 has been 
linked to preeclampisa-eclampsia (Balat et al., 2005). Also, and as expected, numerous 
neuropeptide genes were differentially expressed between female and male gonads based on the 
profiles obtained from study GSE8693.  Neuropeptide genes C-RF, SCG2, TKN1, PDGFA, 
PAHO, IGF1, and PDGFD were over-expressed in males relative to females (maximum P-value 
< 4.0 × 10
-2 
and 1.29 average fold change), and NEU2 was borderline under-expressed (P-value 
< 6.0 × 10
-2
).  The neuropeptide genes with over-expression in females relative to males were 
ADML (P-value < 3.5 × 10
-2
 and 2.98 fold change) and GLUC (P-value < 1.3 × 10
-2
 and 2.84 
fold change). 
 
Other Tissues. The analysis of the gene expression information from experiment GSE8018 
(Nakao et al., 2008), which investigated the effect of day length on quail using the chicken 
microarray platform, identified numerous differentially expressed neuropeptides with unique 
profiles.  The expression of REL3 did not vary within the long-day cycle but was higher at 18 hr 
in the short-day cycle relative to the other time points in the same cycle (overall time-by-day 
cycle interaction P-value < 2.8 × 10
-2
).  The expression of TSHB and cholecystokinin (CCKN) 
did not vary across the day within the day cycle but each was higher in the long-day cycle 
relative to the short-day cycle at every sampled time point (overall time-by-day cycle interaction 
P-value < 5.8 × 10
-6
 and P-value < 1.4 × 10
-4
, respectively).  Lastly, no differential expression 
was found among the neuropeptide genes considered in the studies that compared neural crest 
cells treated with homocysteine versus control (study GSE6868), adipose tissue from lean and fat 
genetic lines (study GSE8010, Wang et al., 2007), circulating red and non-red blood cells (study 
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GSE9884, McIntyre et al., 2008), and histone H1 variants (study GSE8483, Takami and 
Nakayama, 1997). 
 
Prohormone Cleavage Prediction 
An outcome of the comprehensive survey of neuropeptide gene sequences is the ability to predict 
previously unidentified biologically active neuropeptides that can be used in high throughput 
experiments such as proteomic mass spectrometry experiments.  We undertook the first 
prediction of cleavage sites in chicken prohormone sequences to gain insight into neuropeptide 
processing in avian species. The cleavage sites of all 24 chicken prohormone sequences, with 
empirically confirmed sequences and known or predicted neuropeptides available in UniProt 
(summarized in Table 1), were predicted using the empirically derived known motif and the 
human logistic regression cleavage models. The predictions were evaluated against the 
neuropeptides reported in UniProt. The comparison of the cleavage prediction models allows to 
assess the performance of the human cleavage model to predict avian cleavage sites.  
 
The number of true positives (correctly predicted cleaved sites), true negatives (correctly 
predicted non-cleaved sites), false positives (incorrectly predicted cleaved sites), and false 
negatives (incorrectly predicted non-cleaved sites) obtained by the known motif and human 
models, respectively, were 36, 2811, 75, 13 and 35, 2851, 35, 14.  The sensitivity, specificity, 
and correct classification rate of the known motif and human models, respectively, were 73.5, 
97.4, 97.0 and 71.4, 98.8, and 98.3%.  Model performance by individual neuropeptide 
prohormone is presented in Table 5.  Overall, the sensitivity and the specificity of both models to 
predict cleavage was high, especially considering that neither model was trained using chicken 
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sequences.  The highest number of correctly predicted cleavage sites was identified by the 
known motif model, and the highest number of correctly predicted non-cleavage sites was 
identified by the human model.  Thus, the sensitivity (percentage of all cleaved sites that were 
correctly predicted) is higher in the known motif model and the specificity (percentage of all 
non-cleaved sites that were correctly predicted) is higher in the human model.  Although the 
human model correctly predicted 40 additional non-cleaved sites and one less cleaved site, the 
overall difference in correct classification rate was minor (1.3%); this is because of the relatively 
higher number of non-cleaved sites than cleaved sites, which results in more weight for the 
correctly predicted cleaved sites relative to the correctly predicted non-cleaved sites. The 
previous results confirm that the processing of prohormone proteins into neuropeptides is similar 
between chicken and human species. Until more empirically confirmed neuropeptides are 
avilable to train and validate an avian model, the known motif and human models offer a good 
solution for predicting prohormone cleavages and determining the resulting neuropeptides in the 
chicken.   
 
3.4  CONCLUSION 
The role of neuropeptides on reproduction, development, growth, and health has been widely 
recognized.  However, a comprehensive study of the representation and expression of 
neuropeptide genes in chicken has never been undertaken.  In this study, the first survey of 
neuropeptide genes, prohormone sequences, and prohormone convertase enzyme genes in the 
chicken was completed.  The integration of multiple bioinformatic resources allowed us to 
uncover evidence supporting 5 new neuropeptide genes, in addition to the62 previously reported 
in the chicken genome.  Among the 62 chicken neuropeptide genes, 3 genes are not present in 
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Eutherian mammals.  Due to insufficient evidence,  26 neuropeptide genes that are known in 
humans were unable to be detected in the chicken genome. A remarkable finding was that for 
most of the missing genes, another gene in the same neuropeptide family has been identified in 
the chicken genome. This finding suggests that neuropeptide genes have undergone less 
duplication, more gene loss, or both processes in the chicken than in the human.  The high 
correct prediction of cleavage and non-cleavage sites in prohormones obtained with a model 
trained in human sequences indicates that the processing of prohormones into neuropeptides does 
not differ substantially between chicken and human species. 
 
To gain a broad picture of the incidence of neuropeptide genes, we built a panel of expression 
across tissues and developmental stages.  This panel will be of great value in streamlining 
neuropeptide research by helping to identify the tissues and developmental stages most likely to 
exhibit differential neuropeptide gene expression and subsequently, neuropeptide activity. 
Noteworthy findings include identifying the regions with the highest number of neuropeptide 
gene expression reports (brain, head, small intestine, and heart) and the most frequently reported 
expressed genes (PDGFA, SCG1, and ECRG4).  To further understand the role of neuropeptides 
in reproduction, growth, and health, we analyzed the expression of neuropeptide genes across 22 
microarray experiments that evaluated a wide range of ages, genders, tissues, genetic lines, and 
other conditions.  Notable findings include various neuropeptide genes differentially expressed 
between the brain of male and female chickens; these include MCH, ECRG4, GAST, REL3, and 
SCG1.  Also, numerous neuropeptide genes, including PNOC, PDGFA, PDGFB, PDGFD, 
ADML, ECRG4, PENK, and IGF1, were differentially expressed in the breast muscle between 
7- and 0-d-old (just hatched) chickens. Lastly, the expression profiles of the neuropeptide genes 
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ADML, IGF1, VEGFC, VEGFD, and PENK across age differed significantly between broiler 
and layer genetic lines.  
 
The chicken is a fundamental model for avian species, and more insight into the neuropeptide 
complement of this species can be expected from proteomic mass spectrometry studies in the 
chicken and also from the sequencing of the zebra finch, an avian model system used to study 
brain development, learning, and memory (The Zebra Finch Genome Consortium, 2005).  The 
list of chicken neuropeptide genes will also support the annotation of homolog genes in avian 
species with genomes that are in the process of being sequenced and annotated or that do not 
have sequenced genomes.  The series of bioinformatics steps used in this study is applicable to 
surveying neuropeptide or other gene sets in organisms with similar bioinformatics resources.  
The chicken neuropeptide gene sequences and prohormone cleavage prediction approaches are 
available at http://neuroproteomics.scs.uiuc.edu/neuropred.html. The expression panel developed 
here will facilitate neuropeptide research by aiding with identification of the tissues and 
developmental stages most likely to exhibit neuropeptide gene expression and subsequently, 
neuropeptide activity in avian species.
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Table 1. Neuropeptide and convertase gene and protein master list 
 
 
Abbreviated 
Name
Name UniProtID
1
GeneID
2
UniGeneID
3
Evidence 
in 
Chicken
4
ADM2 Intermedin NA
5 NA NA NA
ADML Adrenomedullin NA 423042 Gga.12006 NA
ANF Atrial natriuretic factor P18908 395765 Gga.5157 protein
ANFB Natriuretic peptides B NA NA NA NA
ANFC C-type natriuretic peptide A9CDT6 419487 Gga.12392 transcript
APEL Apelin NA NA NA NA
C-RF AMIDE C-RF amide peptide B0LF68 420716 Gga.3202 predicted
CALC/CALCA
Calcitonin/Calcitonin gene-
related peptide 1
P07660, 
P10286
396256 Gga.4991
transcript/
protein
CALCB
Calcitonin gene-related 
peptide 2
NA NA NA NA
CART
Cocaine- and amphetamine-
regulated transcript 
protein
NA NA NA NA
CCKN Cholecystokinin Q9PU41 414884 Gga.2441 protein
CMGA Chromogranin-A NA 423420 Gga.19002 NA
CNP1
C-type natriuretic peptide 
1
A9CDT5 NA Gga.47230 transcript
COLI Pro-opiomelanocortin Q9YI93 422011 Gga.6271 predicted
CORT Cortistatin NA NA NA NA
CRF Corticoliberin Q703P0 404297 Gga.11323 transcript
ECRG4
Augurin (Esophageal 
cancer-related gene 4 
protein)
NA 771055 Gga.8435 NA
EDN1 Endothelin-1 NA 420854 Gga.25090 NA
EDN2 Endothelin-2 NA 419559 Gga.8238 NA
EDN3 Endothelin-3 Q3MU75 768509 Gga.22840 transcript
GALA Galanin P30802 423117 Gga.12649 protein
GALP Galanin-like peptide NA NA NA NA
GAST Gastrin P09859 396365 Gga.782 protein
GHRL Obestatin
Q8AV73, 
Q7T2V1
408185 Gga.16 homology
GIP
Gastric inhibitory 
polypeptide
A1DPK0 419989 Gga.7981 transcript
GLUC Glucagon P68259 396196 Gga.704 protein
GON1 Progonadoliberin-1 P37042 770134 Gga.41802 protein
GRP Gastrin-releasing peptide P01295 425213 Gga.43422 protein
HEPC Hepcidin NA NA NA NA
IAPP Islet amyloid polypeptide Q90743 396362 Gga.780 transcript
Neuropeptide Prohormone
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Table 1 (cont.) 
 
Abbreviated 
Name
Name UniProtID
1
GeneID
2
UniGeneID
3
Evidence 
in 
Chicken
4
IGF1 Insulin-like growth factor I P18254 418090 Gga.850 protein
IGF2
Insulin-like growth factor 2 
(somatomedin A)
P33717 395097 Gga.8511 protein
INS Insulin  P67970 396145 Gga.673 protein
INSL3 Insulin-like 3 NA NA NA NA
INSL5 Insulin-like 5 NA NA NA NA
INSL6 Insulin-like 6 NA NA NA NA
KISS1
Metastasis-suppressor 
KiSS-1
NA NA NA NA
MCH
Pro-melanin-concentrating 
hormone
 NA 418091 Gga.14659 NA
MOTI Motilin Q9PRP6 768422 NA protein
NEU1 Oxytocin Q2ACD0 768516 NA predicted
NEU2 Neurophysin-II P24787 396101 Gga.652 transcript
NEUT Neurotensin P13724 417883 Gga.10167 protein
NMB Neuromedin-B A0MAR5 415333 Gga.8071 transcript
NMS Neuromedin-S NA NA NA NA
NMU Neuromedin-U P34963 422748 Gga.18392 protein
NPB Neuropeptide B NA NA NA NA
NPFF Neuropeptide FF NA NA NA NA
NPS Neuropeptide S NA NA NA NA
NPW Neuropeptide W NA NA NA NA
NPY Neuropeptide Y P28673 396464 Gga.837 homology
OREX Orexin Q8AV17 374005 Gga.11 transcript
OSTN Osteocrin (Musclin) A5JNH0 424907 Ggta.13448 transcript
OX26
Orexigenic neuropeptide 
QRFP
B2CL09 771867 NA transcript
PACA
Pituitary adenylate cyclase-
activating polypeptide
P41534 408251 Gga.616 protein
PAHO Pancreatic polypeptide P68248 395564 Gga.308 protein
PCSK1N
Proprotein convertase 
subtilisin/kexin type 1 
inhibitor
NA NA NA NA
PDGFA
Platelet-derived growth 
factor alpha polypeptide
Q90WK2, 
Q9PUF7
374196 Gga.3899 transcript
PDGFB
Platelet-derived growth 
factor beta polypeptide
Q90W23 374128 Gga.71 transcript
PDGFD
Platelet derived growth 
factor D
O57658 418978 Gga.43662 transcript
Neuropeptide Prohormone
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Table 1 (cont.) 
 
Abbreviated 
Name
Name UniProtID
1
GeneID
2
UniGeneID
3
Evidence 
in 
Chicken
4
PDYN Proenkephalin-B NA NA NA NA
PENK Proenkephalin NA 421131 Gga.11430 NA
PNOC Prepronociceptin NA 422019 Gga.10041 NA
PROK2 Prokineticin 2 NA 771674 Gga.10528 NA
PRRP Prolactin-releasing peptide A3RJ26 424018 Gga.10552 predicted
PTHR
Parathyroid hormone-
related protein
P17251 396281 Gga.2626 protein
PTHY Parathyroid hormone P15743 396436 Gga.78 homology
PYY Peptide YY P29203 NA NA protein
PYY2 Putative peptide YY-2 NA NA NA NA
REL1 pro-relaxin 1 NA NA NA NA
REL2 pro-relaxin 2 NA NA NA NA
REL3 Relaxin-3 B1AC67 427223 Gga.37019 transcript
RES18
Regulated endocrine-
specific protein 18
NA NA NA NA
RFRP
Neuropeptide VF 
precursor
Q6T2D1, 
Q75XU6
378785 Gga.9285 transcript
RNP Renal natriuretic peptide A9CDT7 NA NA transcript
SCG1 Secretogranin-1 NA 421312 Gga.10025 NA
SCG2 Secretogranin-2 NA 424808 Gga.11999 NA
SECR Secretin P01280 423015 Gga.14227 protein
SLIB Somatoliberin
Q1KNA8, 
Q1KNA7
419178 Gga.11231 transcript
SMS Somatostatin P33094 396279 Gga.742 homology
SPXN  Spexin NA NA NA NA
TAC4/TKN4 Tachykinin-4 NA NA NA NA
TIP39 Parathyroid hormone 2 NA NA NA NA
TKN1 Tachykinin, precursor 1 NA 420573 Gga.12286 NA
TKNK Tachykinin 3 NA NA NA NA
TOR2X Torsin family 2, member A NA NA NA NA
TRH Prothyroliberin Q6ZXC3 414344 Gga.19489 transcript
TSHB
Thyroid-stimulating 
hormone subunit beta
O57340 395937 Gga.551 transcript
UCN1 Urocortin NA NA NA NA
UCN2 Urocortin 2 NA NA NA NA
UCN3 Urocortin 3 NA 769274 Gga.11141 NA
UTS2 Urotensin 2 Q6Q2J6 404535 Gga.14388 transcript
Neuropeptide Prohormone
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Table 1 (cont.) 
 
 
1
: UniProt identifier 
2
: Gene database identifier 
3
: UniGene database identifier 
4
: Evidence in chicken in UniProt at the protein or transcript level, inferred from homology or predicted 
5
: NA= Not available 
Abbreviated 
Name
Name UniProtID
1
GeneID
2
UniGeneID
3
Evidence 
in 
Chicken
4
UTS2D
Urotensin II-related 
peptide
Q6Q273 404534 Gga.9482 transcript
VEGFC
Vascular endothelial 
growth factor C
NA 422573 Gga.12347 NA
VEGFD
Vascular endothelial 
growth factor D
Q8QGD7 395255 Gga.3219 transcript
VIP
Vasoactive intestinal 
peptides
P48143 396323 Gga.666 protein
PCSK1
Proprotein convertase 
subtilisin/kexin type 1
NA 395137 Gga.9357 NA
PCSK2
Proprotein convertase 
subtilisin/kexin type 2
NA 395136 Gga.9404 NA
PCSK3 Furin Q91000 395457 Gga.1751 transcript
PCSK4
Proprotein convertase 
subtilisin/kexin type 4
NA NA NA NA
PCSK5
Proprotein convertase 
subtilisin/kexin type 5
NA 395456 Gga.12660 NA
PCSK6
Proprotein convertase 
subtilisin/kexin type 6
NA 395454 Gga.21090 NA
PCSK7
Proprotein convertase 
subtilisin/kexin type 7
Q5ZKB5 395455 Gga.5311 transcript
Neuropeptide Prohormone
Prohormone Convertase Enzyme
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Table 2. Abbreviated distribution of neuropeptide and convertase gene EST across tissues and stages 
 
Neuropeptide 
Prohormones 
Unigene 
ID
1
Brain Head Ovary
Small 
Intestine
Embryo 
Stage
Adult 
Stage
ADML Gga.12006 1
2
0 0 0 1 1
ANF Gga.5157 1 0 0 0 1 1
ANFC Gga.12392 1 0 0 0 0 1
C-RF AMIDE Gga.3202 1 1 1 0 1 1
CALCA Gga.4991 1 1 0 0 1 0
CCKN Gga.2441 1 0 1 1 1 1
CMGA Gga.19002 1 1 1 1 1 1
COLI Gga.6271 1 0 0 0 0 0
ECRG4 Gga.8435 1 1 1 1 1 1
EDN1 Gga.25090 0 0 0 0 1 1
EDN2 Gga.8238 1 0 1 1 1 1
EDN3 Gga.22840 0 0 1 0 1 1
GALA Gga.12649 0 0 0 1 0 1
GHRL Gga.16 0 0 1 0 1 1
GIP Gga.7981 0 0 0 1 0 1
GLUC Gga.704 0 1 0 1 1 1
GRP Gga.43422 0 0 0 0 0 0
IAPP Gga.780 1 1 0 0 1 1
IGF1 Gga.850 0 0 1 0 0 1
IGF2 Gga.8511 0 0 0 0 0 1
INS Gga.673 0 0 1 0 0 1
MCH Gga.14659 1 0 0 0 1 0
NEU2 Gga.652 1 0 0 0 1 1
NEUT Gga.10167 1 1 0 1 1 1
NMB Gga.8071 1 0 0 0 1 1
NMU Gga.18392 1 0 0 1 1 1
NPY Gga.837 1 0 1 0 1 1
OREX Gga.11 0 0 0 0 1 0
OSTN Gga.13448 0 1 0 0 1 1
PACA Gga.616 1 1 0 0 1 1
PDGFA Gga.3899 1 1 1 1 1 1
PDGFB Gga.71 1 1 1 0 1 1
PDGFD Gga.43662 1 1 0 0 1 1
PENK Gga.11430 1 1 1 0 1 1
PNOC Gga.10041 1 0 0 0 1 0
PROK2 Gga.10528 1 0 1 0 1 1
PRRP Gga.10552 0 0 1 0 0 1
PTHR Gga.2626 0 0 0 0 1 0
REL3 Gga.37019 1 0 1 0 1 1
RFRP Gga.9285 1 1 0 0 1 1
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Table 2 (cont.) 
 
 
1
: UniGene database identifier 
2
: 1 denotes presence and 0 denotes absence 
Neuropeptide 
Prohormones 
Unigene 
ID
1
Brain Head Ovary
Small 
Intestine
Embryo 
Stage
Adult 
Stage
SCG1 Gga.10025 1 1 1 0 1 1
SCG2 Gga.11999 1 1 0 0 1 1
SECR Gga.14227 0 0 0 1 0 1
SLIB Gga.11231 1 1 0 0 1 0
SMS Gga.742 1 0 0 1 1 1
TKN1 Gga.12286 1 0 0 1 0 1
UCN3 Gga.11141 0 0 0 1 0 1
UTS2D Gga.9482 0 1 0 0 1 0
VEGFC Gga.12347 0 1 0 0 1 1
VEGFD Gga.3219 1 1 1 1 1 1
VIP Gga.666 1 1 0 1 1 1
Total 33 7 2 6 8 9
Prohormone 
Convertases 
PCSK1 Gga.9357  N/A N/A N/A N/A N/A N/A
PCSK1 similar Gga.31439 1 0 0 1 1 1
PCSK2 Gga.9404 1 1 0 1 1 1
PCSK3 Gga.1751 1 0 0 0 0 1
PCSK5 Gga.12660 1 0 1 1 1 1
PCSK6 Gga.21090 0 0 1 1 1 1
PCSK7 Gga.5311 1 1 1 1 1 1
Total 5 2 3 5 5 6
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Table 3. Abreviated description of the 22 chicken microarray experiments analyzed
Exp. ID
1 Tissue Gender Age Reference
GSE6543 Retina Female 1-wk McGlinn et al.. (2007)
GSE6843 Embryonic heart M/F
2 Late stage embryo Itoh et al. (2007)
GSE6844 Embryonic brain M/F Late stage embryo Itoh et al. (2007)
GSE6856 Embryonic liver M/F Late stage embryo Itoh et al. (2007)
GSE6868 Neural tube explants NA
3 Stage 9+ embryo Rosenquist et al. (2007)
GSE7176 Retinal epithelium NA 7-d-old embryo Rizzolo et al. (2007)
GSE8010 Adipose Tissue Female 7-wk Wang et al. (2007)
GSE8016 Liver Female NA Nakao et al. (2008)
GSE8018 Hypothalamus NA NA Nakao et al. (2008)
GSE8483 DT40 cells NA NA Takami et al. (1997)
GSE8693 Embryonic heart M/F 18-d-old embryo Ellegren et al. (2007)
GSE8693 Embryonic brain M/F 18-d-old embryo Ellegren et al. (2007)
GSE8693 Embryonic gonad M/F 18-d-old embryo Ellegren et al. (2007)
GSE9251 Pectoralis muscles Female 1-d-old to 8-wk-old Zheng et al. (2009)
GSE9884 Embryonic heart blood NA Embryo McIntyre et al. (2008)
GSE10231 F1 oocyte stage Female NA NA
GSE11439 Retina Male 9-d-old Schippert et al. (2008)
GSE12268 Brain M/F Stage 29 embryo NA
GSE15382 Retina NA Embryo Kubo et al. (2009)
GSE15413 Liver NA Newly hatched/7-d-old NA
GSE15413 Brain NA Newly hatched/7-d-old NA
GSE15413 Duodenum NA Newly hatched/7-d-old NA 
1
: ID = Identifer
2
: M/F = Male and Female
3
: NA= Not available
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Table 4. Number of differentially expressed neuropeptide and convertase genes (P-value < 0.005) across 22 
microarray studies grouped by tissue type 
 
 
Prohormone UniGene Probe
1 Retina
Heart-
breast
Brain-
head
Liver-
duod.
2
Oocyte-
gonad
Others
Total by 
Probe 
ADML Gga.12006.1.S1_at 1 2 0 0 1 1 5
ANF Gga.5157.1.S1_at 0 0 0 0 0 0 0
ANFC Gga.12392.1.S1_a_at 0 1 0 0 0 1 2
CALCA Gga.4991.2.S1_a_at 1 0 0 0 0 0 1
CCKN GgaAffx.21834.1.S1_s_at 0 0 0 0 0 1 1
CCKN Gga.2441.1.S1_at 0 0 0 0 0 0 0
CMGA GgaAffx.21576.1.S1_s_at 1 1 0 1 0 1 4
CMGA Gga.12437.2.S1_at 0 1 0 0 0 0 1
COLI Gga.6271.1.S1_at 0 1 0 0 0 1 2
CRF Gga.11323.1.S1_at 0 0 0 0 1 0 1
ECRG4 Gga.8435.1.S1_at 0 2 0 0 0 1 3
ECRG4 Gga.11232.1.A1_at 0 1 0 0 0 0 1
GALA Gga.12649.1.S1_at 0 0 0 0 0 0 0
GAST Gga.782.1.S1_at 0 1 0 0 0 0 1
GHRL Gga.16.1.S1_at 0 0 0 0 0 0 0
GIP Gga.7981.1.S1_at 0 1 0 0 0 0 1
GLUC GgaAffx.21780.2.S1_s_at 0 0 0 0 1 0 1
IAPP Gga.780.1.S1_at 0 1 0 0 0 0 1
IGF1 Gga.850.1.S1_at 0 2 0 1 1 0 4
IGF2 Gga.8511.1.S1_at 0 1 0 0 0 1 2
INS Gga.673.1.S1_at 0 0 0 1 0 1 2
MCH Gga.14659.1.S1_at 0 0 1 0 0 0 1
NEU2 Gga.652.1.S1_at 0 0 0 0 0 0 0
NEUT Gga.10167.1.S1_at 1 0 0 0 0 0 1
NMB Gga.8071.1.S1_a_at 0 0 0 0 0 0 0
NMU Gga.18392.1.S1_at 0 1 0 1 0 1 3
NPY Gga.837.1.S1_a_at 0 0 0 0 0 1 1
OREX Gga.11.1.S1_at 0 0 0 0 0 0 0
OSTN Gga.13448.1.S1_at 0 1 0 0 0 0 1
PACA Gga.11409.1.S1_at 0 1 0 0 0 0 1
PACA Gga.616.1.S1_s_at 0 0 0 0 0 0 0
PAHO Gga.308.1.S1_at 0 0 0 0 1 0 1
PDGFA Gga.3899.3.S1_a_at 1 1 0 0 1 0 3
PDGFB Gga.71.1.S1_at 0 1 0 0 0 0 1
PDGFD Gga.9675.1.S1_at 0 2 0 0 1 0 3
PENK Gga.11430.1.S1_at 0 2 0 1 0 0 3
PNOC Gga.10041.1.S1_a_at 0 2 0 0 0 0 2
PNOC Gga.10041.2.A1_at 0 1 0 0 0 1 2
PNOC GgaAffx.20191.1.S1_s_at 0 0 0 0 0 0 0
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Table 4 (cont.) 
 
Prohormone UniGene Probe
1 Retina
Heart-
breast
Brain-
head
Liver-
duod.
2
Oocyte-
gonad
Others
Total by 
Probe 
PROK2 Gga.10528.1.S1_a_at 0 0 0 1 0 0 1
PROK2 Gga.10528.2.A1_at 0 0 0 0 0 0 0
PRRP Gga.10552.1.S1_at 0 1 0 0 0 0 1
PTHR Gga.2626.1.S1_at 0 1 0 0 0 1 2
PTHY Gga.78.1.A1_at 0 0 0 0 0 0 0
REL3 Gga.12454.1.S1_at 0 0 1 0 0 2 3
RFRP Gga.9285.1.S1_at 0 0 0 0 0 1 1
SCG1 Gga.10025.1.S1_at 0 0 1 0 0 0 1
SCG2 Gga.11999.1.S1_at 0 0 0 0 0 0 0
SCG2 Gga.11999.1.A1_s_at 0 1 0 0 1 0 2
SCG2 Gga.11999.1.A1_at 0 0 0 0 0 0 0
SECR Gga.14227.1.S1_at 0 0 0 0 0 0 0
SLIB Gga.11231.1.S1_at 0 0 0 0 0 0 0
SMS Gga.742.1.S1_at 0 1 0 0 0 0 1
TKN1 Gga.12286.1.S1_at 0 1 0 0 1 0 2
TRH Gga.19489.1.A1_at 0 1 0 0 0 0 1
TRH Gga.19489.1.S1_at 0 0 0 0 0 0 0
TSHB Gga.551.1.S1_at 0 1 0 0 0 1 2
UCN3 Gga.11141.1.S1_at 0 0 0 0 0 0 0
UTS2 Gga.14388.1.S1_at 0 0 0 0 0 0 0
UTS2D Gga.9482.1.S1_at 2 0 0 0 0 0 2
VEGFC Gga.12347.1.S1_at 1 1 0 0 0 0 2
VEGFD Gga.3219.1.S1_at 1 1 0 0 0 0 2
VIP Gga.666.1.S1_a_at 1 0 1 0 0 0 2
Total by Tissue 10 36 4 6 9 16 81
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Table 4 (cont.) 
 
 
1: UniGene identifier of microarray gene probe 
2: Duodenum 
 
 
 
 
 
 
 
 
 
 
 
 
Prohormone 
Convertases
UniGene Probe
1 Retina
Heart-
breast
Brain-
head
Liver-
duod.
2
Oocyte-
gonad
Others
Total by 
Probe 
PCSK2 Gga.2786.1.S1_at 0 1 0 0 0 0 1
PCSK2 Gga.9404.1.S1_at 0 0 0 0 0 0 0
PCSK3 Gga.1751.1.S1_at 0 0 0 0 1 0 1
PCSK5 Gga.247.1.S1_at 1 0 0 0 0 0 1
PCSK5 Gga.12660.2.S1_a_at 0 0 0 0 0 1 1
PCSK6 Gga.20041.1.S1_at 0 1 0 1 1 0 3
PCSK6 GgaAffx.20832.1.S1_s_at 0 0 0 0 1 0 1
PCSK6 Gga.246.1.S1_at 0 0 0 0 0 0 0
PCSK7 GgaAffx.12272.1.S1_s_at 0 0 0 0 0 0 0
PCSK7 Gga.17539.1.S1_s_at 0 0 0 0 1 0 1
Total by Tissue 1 2 0 1 4 1 9
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Table 5. Evaluation of the prediction of cleavage sites in chicken prohormone sequences  
 
 
1
: TP: true positives; TN: true negatives; FP: false positives;  FN: false negatives; positives=cleavage sites;  
 negatives=non-cleavage sites 
2
: Correct classification rate 
Known Motif Model Human Model
Neuropeptide 
Prohormone
TP TN FP FN TP TN FP FN
ANF 0 107 4 1 0 107 4 1
CALC 2 105 2 0 2 107 0 0
CALCA 2 91 3 0 1 93 1 1
CCKN 2 102 0 2 2 102 0 2
GALA 2 88 0 0 1 88 0 1
GLUC 5 171 2 2 5 173 0 2
GON1 1 63 1 0 1 64 0 0
GRP 1 104 0 1 2 103 1 0
IGF1 0 96 4 1 0 100 0 1
IGF2 0 152 7 1 0 156 3 1
INS 2 77 0 0 2 77 0 0
MOTI 1 85 0 0 1 85 0 0
NEU2 1 135 2 0 1 136 1 0
NEUT 2 137 2 0 2 137 2 0
NMU 2 125 4 1 3 129 0 0
NPY 1 62 1 0 1 63 0 0
PACA 3 139 5 1 3 142 2 1
PAHO 1 49 1 0 1 49 1 0
PTHR 2 133 12 0 2 142 3 0
PTHY 1 86 3 0 1 88 1 0
SECR 2 126 1 0 1 127 0 1
SMS 1 86 0 1 1 86 0 1
TRH 0 218 14 0 0 220 12 0
TSHB 0 112 2 0 0 113 1 0
VIP 2 162 5 2 2 164 3 2
Total 36 2811 75 13 35 2851 35 14
Sensitivity 73.5% 71.4%
Specificity 97.4% 98.8%
CCR
2 97.0% 98.3%
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1
: The supplementary materials can be accessed in Neuropeptides from the  manuscript: Delfino, 
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of chicken neuropeptide and prohormone convertase genes). In Press as of November 20, 2009. 
